image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
193ee6cf1d72b80bab84c9e60e663741e99e04fb370a9bb20eaef52612bcd26f.png | simple | <table><tr><td>Properties</td><td>Year</td><td>Crop</td><td>Stages</td><td>pH</td><td>Organic C</td><td>K<sub>2</sub>O</td><td>S</td><td>Zn</td><td>Fe</td><td>Mn</td><td>Mineral- N</td><td>Actinomycetes population</td></tr><tr><td>Year</td><td>1</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td>... | <table><tr><td>Properties</td><td>Year</td><td>Crop</td><td>Stages</td><td>pH</td><td>Organic C</td><td>K2O</td><td>S</td><td>Zn</td><td>Fe</td><td>Mn</td><td>Mineral- N</td><td>Actinomycetes population</td></tr><tr><td>Year</td><td>1</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td>... | <table><tr><td>Zn</td><td>-0.02</td><td>0.34</td><td>0.37</td><td>0.66**</td><td>0.93**</td><td>0.45**</td><td>0.40</td><td>1</td><td></td><td></td><td></td><td></td></tr><tr><td>Fe</td><td>-0.98</td><td>0.24</td><td>0.35</td><td>0.52*</td><td>0.73**</td><td>0.11</td><td>0.25</td><td>0.67</td><td>1</td><td></td><td></t... |
c92dc921e457c1e455040d2661a1389a8306abdd65128a1a29f4ea25e7b2cc5c.png | simple | <table><tr><td>Citation</td><td>Type of study</td><td>Sample</td><td>Gene</td><td>Clinical assessments</td><td>Main findings</td></tr><tr><td>Tsao <i>et al</i>. 2006 [22]</td><td>Case-control and follow-up</td><td>20 MDD22 Controls</td><td><i>5-HTT</i><i>IL-1β</i><i>IL-6</i><i>TNF-α</i><i>IFN-α</i></td><... | <table><tr><td>Citation</td><td>Type of study</td><td>Sample</td></tr><tr><td>Tsao et al. 2006 [22]</td><td>Case-control and follow-up</td><td>20 MDD22 Controls</td></tr><tr><td>Cattaneo et al. 2012 [23]</td><td>Case-control and follow-up</td><td>74 MDD34 Controls</td></tr><tr><td>Suzuki et al. 2010 [25]</td><td>Case-c... | <table><tr><td>Gene</td><td>Clinical assessments</td><td>Main findings</td></tr><tr><td>5-HTTIL-1βIL-6TNF-αIFN-α</td><td>Diagnosis based on DSM-IV criteriaHDRS</td><td>Higher expression of 5-HTT, IL-1β, IL-6, TNF-α and IFN-α in patients with MDD compared with controls. Significant decreased in expression of 5-HTT and I... |
5e78a861f201d930e7e3a485756f897049e5cd29fac265d21425101c1b3a1397.png | complex | <table><tr><td>Symptoms</td><td>Mild</td><td>Moderate</td><td>Severe</td><td>Total</td></tr><tr><td>Age groups (year)</td><td>frequency (%)</td><td>frequency (%)</td><td>frequency (%)</td><td>frequency (%)</td></tr><tr><td><10</td><td>89 (8.3)</td><td>2 (9.5)</td><td>3 (4.9)</td><td>94 (8.2)</td></tr><tr><td>10̵... | <table><tr><td>Symptoms</td><td>Mild</td><td>Moderate</td><td>Severe</td><td>Total</td></tr><tr><td>Age groups (year)</td><td>frequency (%)</td><td>frequency (%)</td><td>frequency (%)</td><td>frequency (%)</td></tr></table> | <table><tr><td><10</td><td>89 (8.3)</td><td>2 (9.5)</td><td>3 (4.9)</td><td>94 (8.2)</td></tr><tr><td>10–19</td><td>168 (15.7)</td><td>3 (14.3)</td><td>9 (14.8)</td><td>180 (15.6)</td></tr><tr><td>20–29</td><td>355 (33.2)</td><td>5 (23.8)</td><td>22 (36.1)</td><td>382 (33.2)</td></tr><tr><td>30–39</td><td>165 (15.4)</t... |
518b120a1b6d2b023dd8eb3406075e25299daf49be04dc2e7778b9d1a8ddb4aa.png | complex | <table><tr><td></td><td colspan="3">Number of patients</td><td colspan="3">Number of procedures</td><td colspan="2">Efficiency</td></tr><tr><td></td><td>2010</td><td>2011</td><td>Total</td><td>2010</td><td>2011</td><td>Total</td><td>2010</td><td>2011</td></tr><tr><td>EPS 1</td><td>242</td><td>350</td><td>592</td><td>74... | <table><tr><td></td><td colspan="3">Number of patients</td><td colspan="3">Number of procedures</td><td colspan="2">Efficiency</td></tr><tr><td></td><td>2010</td><td>2011</td><td>Total</td><td>2010</td><td>2011</td><td>Total</td><td>2010</td><td>2011</td></tr><tr><td>EPS 1</td><td>242</td><td>350</td><td>592</td><td>74... | <table><tr><td>EPS 2</td><td>102</td><td>84</td><td>186</td><td>1566</td><td>1185</td><td>2751</td><td>0,651</td><td>0,562</td></tr></table> |
71a480e811d613cc3167d87f1630f2f1e28665a8fc5bb47927ffd6bc2c2372a6.png | complex | <table><tr><td>Signaling questions</td><td>Answer</td><td>Risk of bias/applicability</td><td>Planned adjustment</td></tr><tr><td>Domain 1: Patient selection</td><td> </td><td> </td><td> </td></tr><tr><td>Risk of bias</td><td> </td><td>Low risk</td><td> </td></tr><tr><td>Is a consecutive sample of patients enrolled?</td... | <table><tr><td>Signaling questions</td><td>Answer</td><td>Risk of bias/applicability</td><td>Planned adjustment</td></tr><tr><td>Domain 1: Patient selection</td><td></td><td></td><td></td></tr></table> | <table><tr><td>Risk of bias</td><td></td><td>Low risk</td><td></td></tr><tr><td>Is a consecutive sample of patients enrolled?</td><td>Yes</td><td></td><td></td></tr><tr><td>Is a case-control design avoided?</td><td>Yes</td><td></td><td></td></tr><tr><td>Does the study avoid inappropriate exclusions?</td><td>Yes</td><td... |
d555ad9a841400f8edfcfb5ad357b4fb3f386a2bbee3ca2c543c96280c679061.png | simple | <table><tr><td>Variable</td><td>Magnesium (% (<i>n</i>))</td><td>Control (% (<i>n</i>))</td><td><i>x</i><sup>2 </sup>value</td><td><i>P </i>value</td><td>Total prevalence (% (<i>n</i>))</td></tr><tr><td>Diabetes mellitus [11,24-26]</td><td>22.4 (68/304)</td><td>21.9 (70/319)</td><td>0.016</td><td>0.9</td><td>22.2 (138/... | <table><tr><td>Variable</td><td>Magnesium (% (n))</td><td>Control (% (n))</td><td>x2 value</td><td>P value</td><td>Total prevalence (% (n))</td></tr><tr><td>Diabetes mellitus [11,24-26]</td><td>22.4 (68/304)</td><td>21.9 (70/319)</td><td>0.016</td><td>0.9</td><td>22.2 (138/623)</td></tr></table> | <table><tr><td>Hypertension [24-26]</td><td>31.2 (43/138)</td><td>27.1 (38/140)</td><td>0.543</td><td>0.5</td><td>29.1 (81/278)</td></tr><tr><td>β-blocker [21-25]</td><td>45.6 (146/320)</td><td>48.6 (152/313)</td><td>0.548</td><td>0.5</td><td>47.1 (298/633)</td></tr></table> |
f3629e08b3bc9c8dcaa4b5852205a6d14f4ebebb958286fe1a96d426bfce36ba.png | complex | <table><tr><td> </td><td colspan="6">Number (%) of mice with viable GAS in tissues</td></tr><tr><td> </td><td colspan="2">Blood</td><td colspan="2">Spleen</td><td colspan="2">Liver</td></tr><tr><td>Time (h) from defined injury to infection</td><td>Trauma</td><td>Control</td><td>Trauma</td><td>Control</td><td>Trauma</td... | <table><tr><td></td><td colspan="6">Number (%) of mice with viable GAS in tissues</td></tr><tr><td></td><td colspan="2">Blood</td><td colspan="2">Spleen</td><td colspan="2">Liver</td></tr></table> | <table><tr><td>Time (h) from defined injury to infection</td><td>Trauma</td><td>Control</td><td>Trauma</td><td>Control</td><td>Trauma</td><td>Control</td></tr><tr><td>0*</td><td>4/5(80%)</td><td>4/4(100%)</td><td>4/5(80%)</td><td>(3/4)(75%)</td><td>3/5(60%)</td><td>2/4(50%)</td></tr><tr><td>24</td><td>3/6(50%)</td><td>... |
a18b8c3c318991dfec71b16d56b3aed18d7e0acf7df5dbf260aa24d3556311a4.png | complex | <table><tr><td><i>Strategy</i></td><td colspan="3"><i>Clusters of terms</i></td></tr><tr><td> </td><td><i>#clusters</i></td><td><i>Interval</i></td><td><i>Mean</i></td></tr><tr><td>Semantic distance</td><td>7,564</td><td>[2; 1,354]</td><td>132.67</td></tr><tr><td>Terminology structuring</td><td>748</td><td>[1; 119]</td... | <table><tr><td>Strategy</td><td colspan="3">Clusters of terms</td></tr><tr><td></td><td>#clusters</td><td>Interval</td><td>Mean</td></tr><tr><td>Semantic dista</td><td>7,56</td><td>[2; 1,35</td><td></td></tr></table> | <table><tr><td>Strategy</td><td colspan="3">Clusters of terms</td></tr><tr><td></td><td>#clusters</td><td>Interval</td><td>Mean</td></tr><tr><td>nce</td><td>4</td><td>4]</td><td>132.67</td></tr><tr><td>Terminology structuring</td><td>748</td><td>[1; 119]</td><td>3.82</td></tr><tr><td>(hierarchical+synonymy)</td><td></t... |
b9d50b11a3f3512b0a6dcce540c33f2e5f530323c152f5778a5fb18ad26ad0db.png | complex | <table><tr><td rowspan="2"> </td><td colspan="4">Original Network</td><td colspan="4">Simplified Network</td></tr><tr><td><i>Se</i></td><td><i>Sp</i></td><td><i>Pr</i></td><td><i>F</i></td><td><i>Se</i></td><td><i>Sp</i></td><td><i>Pr</i></td><td><i>F</i></td></tr><tr><td>Proposed Method</td><td>0.63</td><td>1.0</td><t... | <table><tr><td rowspan="2"></td><td colspan="4">Original Network</td><td colspan="4">Simplified Network</td></tr><tr><td>Se</td><td>Sp</td><td>Pr</td><td>F</td><td>Se</td><td>Sp</td><td>Pr</td><td>F</td></tr><tr><td>Proposed Method</td><td>0.63</td><td>1.0</td><td>1.0</td><td>0.77</td><td>0.67</td><td>1.0</td><td>1.0</... | <table><tr><td>BANJO</td><td>0.25</td><td>0.76</td><td>0.33</td><td>0.27</td><td>0.50</td><td>0.70</td><td>0.50</td><td>0.50</td></tr></table> |
63ec3b2f8214a596e145d632825227847b309b4b32578ba03d4ffdaf70404987.png | complex | <table><tr><td></td><td colspan="2">Males (n = 518)</td><td colspan="2">Females (n = 626)</td></tr><tr><td></td><td><i>BP < 140/90 n = 195</i></td><td><i>SBP ≥ 140 or DBP ≥ 90 n = 323</i></td><td><i>BP=<140/90 n = 183</i></td><td><i>SBP ≥ 140 or DBP ≥ 90 n = 443</i></td></tr><tr><td>Cardio... | <table><tr><td></td><td colspan="2">Males (n = 518)</td><td colspan="2">Females (n = 626)</td></tr><tr><td></td><td>BP < 140/90 n = 195</td><td>SBP ≥ 140 or DBP ≥ 90 n = 323</td><td>BP=<140/90 n = 183</td><td>SBP ≥ 140 or DBP ≥ 90 n = 443</td></tr><tr><td>Cardiovascular disease</td><td>130 (66.7)</td><td>131 (40.6)**</... | <table><tr><td>Education < 12 years</td><td>68 (65.4)</td><td>113 (64.9)</td><td>81 (86.2)</td><td>223 (86.4)</td></tr><tr><td>Depressed mood</td><td>5 (3.1)</td><td>6 (2.1)</td><td>11 (8.1)</td><td>21 (6.3)</td></tr><tr><td>Less than good general health</td><td>76 (40.2)</td><td>104 (33.0)</td><td>94 (53.1)</td><td>19... |
ca801fab6099f58d29ca76a5ec089229bd41ea1eaffa682d3399b2ef61b25d30.png | simple | <table><tr><td>Land cover class</td><td>Description</td></tr><tr><td>Crops, agricultural and open savannah</td><td>Agricultural land or grassland with occasional trees/bushes (not seasonally flooding)</td></tr><tr><td>Woodland and dense savannah</td><td>Grassland with dense trees/bushes (not seasonally flooding) and pa... | <table><tr><td>Land cover class</td><td>Description</td></tr><tr><td>Crops, agricultural and open savannah</td><td>Agricultural land or grassland with occasional trees/bushes (not seasonally flooding)</td></tr><tr><td>Woodland and dense savannah</td><td>Grassland with dense trees/bushes (not seasonally flooding) and pa... | <table><tr><td>Land cover class</td><td>Description</td></tr><tr><td>Seasonally flooded grassland</td><td>Savannah which floods during the wet season, with occasional trees/bushes</td></tr></table> |
6103beab13f8f8cfa9e66e9ded97c08e77421062e7a7b3881c8e06f0071451d7.png | simple | <table><tr><td>No. of suicide attempts by self-poisoning per case (<i>i</i>)</td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>≥7</td></tr><tr><td>No. of cases (<i>n<sub>i</sub></i>)</td><td>---</td><td>1,069</td><td>334</td><td>156</td><td>78</td><td>32</td><td>15</td><td>30</td></tr>... | <table><tr><td>No. of suicide attempts by self-poisoning per case (i)</td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>≥7</td></tr></table> | <table><tr><td>No. of cases (ni)</td><td>---</td><td>1,069</td><td>334</td><td>156</td><td>78</td><td>32</td><td>15</td><td>30</td></tr></table> |
f6cb15fa1f9f468b9e8f2c5dac8c858e7718173c1c01dac997f9481690e989f9.png | simple | <table><tr><td>Trait</td><td>Montbéliarde</td><td>Normande</td><td>Holstein</td></tr><tr><td> </td><td>[HPD95%]</td><td>[HPD95%]</td><td>[HPD95%]</td></tr><tr><td>Milk</td><td>0.33 / 0.30*</td><td>0.33/ 0.30*</td><td>0.37 / 0.30*</td></tr><tr><td> </td><td>[0.29 ; 0.38]</td><td>[0.29 ; 0.38]</td><td>[0.33 ; 0.41]... | <table><tr><td>Trait</td><td>Montbéliarde</td><td>Normande</td><td>Holstein</td></tr><tr><td></td><td>[HPD95%]</td><td>[HPD95%]</td><td>[HPD95%]</td></tr><tr><td>Milk</td><td>0.33 / 0.30*</td><td>0.33/ 0.30*</td><td>0.37 / 0.30*</td></tr><tr><td></td><td>[0.29 ; 0.38]</td><td>[0.29 ; 0.38]</td><td>[0.33 ; 0.41]</td></... | <table><tr><td>content</td><td>.42/ 0.50*</td><td>0.50*</td><td> / 0.50*</td></tr><tr><td></td><td>[0.36 ; 0.46]</td><td>[0.39 ; 0.49]</td><td>[0.45 ; 0.51]</td></tr><tr><td>Fertility</td><td>0.05 / 0.02*</td><td>0.06 / 0.02*</td><td>0.08 / 0.02*</td></tr><tr><td></td><td>[0.04 ; 0.06]</td><td>[0.04 ; 0.07]</td><td>[0.... |
ce2b7b91f9cb664595e067e83f1885a558c5bf34cce9707c464893324348bbf2.png | complex | <table><tr><td>Variable</td><td colspan="2">Study group</td><td><i>P </i>value</td></tr><tr><td></td><td>Hyal-Joint<sup>® </sup>(<i>n </i>= 11)</td><td>Placebo (<i>n </i>= 9)</td><td></td></tr><tr><td>Men/women</td><td>4/7</td><td>5/4</td><td>0.653</td></tr><tr><td>Age, years, mean (SD)</td><td>57.7 (10.1)</td><td... | <table><tr><td>Variable</td><td colspan="2">Study group</td><td>P value</td></tr></table> | <table><tr><td></td><td>Hyal-Joint® (n = 11)</td><td>Placebo (n = 9)</td><td></td></tr><tr><td>Men/women</td><td>4/7</td><td>5/4</td><td>0.653</td></tr><tr><td>Age, years, mean (SD)</td><td>57.7 (10.1)</td><td>54.6 (7.7)</td><td>0.448</td></tr><tr><td>Ethnicity</td><td></td><td></td><td>0.361</td></tr><tr><td>Black</td... |
61e7884bd84980aa976b5e4ffedf30023144ae77b8d1f020d518615c1d63b8be.png | complex | <table><tr><td></td><td>Min</td><td>Q1</td><td>Median</td><td>Q3</td><td>Max</td></tr><tr><td colspan="6"><i>Village prevalence (%)</i></td></tr><tr><td>Situation 1 <sup>a</sup></td><td>0.32</td><td>2.39</td><td>3.72</td><td>5.23</td><td>12.1</td></tr><tr><td>Situation 2 <sup>b</sup></td><td>0.95</td><td>2.07</td><td>4... | <table><tr><td></td><td>Min</td><td>Q1</td><td>Median</td><td>Q3</td><td>Max</td></tr><tr><td colspan="6">Village prevalence (%)</td></tr><tr><td>Situation 1 a</td><td>0.32</td><td>2.39</td><td>3.72</td><td>5.23</td><td>12.1</td></tr><tr><td>Situation 2 b</td><td>0.95</td><td>2.07</td><td>4.5</td><td>5.79</td><td>12.3<... | <table><tr><td>tion 1 a</td><td></td><td>.51</td><td>3.54</td><td></td><td>2</td></tr><tr><td>Situation 2 b</td><td>1.52</td><td>2.41</td><td>4.06</td><td>4.72</td><td>7.26</td></tr></table> |
05da0a473078abcdb157eaf0dd1d19d43e37153389184802e3fc68ab49a87fc9.png | complex | <table><tr><td></td><td colspan="2">Baseline</td><td colspan="2">Endline</td></tr><tr><td>Messages</td><td>Nutrition-focused MNCH<sup>2</sup> (<i>n</i> = 747)</td><td>Standard MNCH (<i>n</i> = 767)</td><td>Nutrition-focused MNCH<sup>2</sup> (<i>n</i> = 622)</td><td>Standard MNCH (<i>n</i> = 685)</td></tr><tr><td>Proper... | <table><tr><td></td><td colspan="2">Baseline</td><td colspan="2">Endline</td></tr><tr><td>Messages</td><td>Nutrition-focused MNCH2 (n = 747)</td><td>Standard MNCH (n = 767)</td><td>Nutrition-focused MNCH2 (n = 622)</td><td>Standard MNCH (n = 685)</td></tr><tr><td>Proper diet every day during pregnancy ensures weight ga... | <table><tr><td>Proper diet during pregnancy will ensure that the child will be brainy</td><td>49.7</td><td>53.7</td><td>86.0**</td><td>61.9</td></tr><tr><td>Pregnant women should consume ≥5 different food groups daily</td><td>20.6</td><td>24.0</td><td>83.6***</td><td>16.4</td></tr><tr><td>Nutritious food is not always ... |
4eef5e4a88ca8dc43d1e1f4669d138214f7d5f4eb906eccaa041cb17529ad578.png | simple | <table><tr><td>Case</td><td>Age (years)</td><td>Sex</td><td>Physical activity</td><td>Level affected</td></tr><tr><td>1</td><td>9</td><td>Girl</td><td>Jumping rope</td><td>T5</td></tr><tr><td>2</td><td>9</td><td>Boy</td><td>Jumping rope</td><td>T6</td></tr><tr><td>3</td><td>10</td><td>Boy</td><td>Handstand</td><td>T11<... | <table><tr><td>Case</td><td>Age (years)</td><td>Sex</td><td>Physical activity</td><td>Level affected</td></tr><tr><td>1</td><td>9</td><td>Girl</td><td>Jumping rope</td><td>T5</td></tr></table> | <table><tr><td>Case</td><td>Age (years)</td><td>Sex</td><td>Physical activity</td><td>Level affected</td></tr><tr><td>2</td><td>9</td><td>Boy</td><td>Jumping rope</td><td>T6</td></tr><tr><td>3</td><td>10</td><td>Boy</td><td>Handstand</td><td>T11</td></tr><tr><td>4</td><td>11</td><td>Boy</td><td>Jumping rope</td><td>T7<... |
7c304f2b97d8607ab98cc7a17d28db9de4bcd84986d7426a66ceebbaed5385e3.png | simple | <table><tr><td>Characteristics</td><td>Mean</td><td>Standard deviation</td></tr><tr><td>Age (years)</td><td>25</td><td>1,0</td></tr><tr><td>Body mass index (kg/m<sup>2</sup>)</td><td>23,9</td><td>1,9</td></tr><tr><td>Waist size (cm)</td><td></td><td></td></tr><tr><td> Male</td><td>79</td><td>5,0</td></tr><tr><td> Femal... | <table><tr><td>Characteristics</td><td>Mean</td><td>Standard deviation</td></tr><tr><td>Age (years)</td><td>25</td><td>1,0</td></tr><tr><td>Body mass index (kg/m2)</td><td>23,9</td><td>1,9</td></tr><tr><td>Waist size (cm)</td><td></td><td></td></tr><tr><td>Male</td><td>79</td><td>5,0</td></tr><tr><td>Female</td><td>76<... | <table><tr><td>Characteristics</td><td>Mean</td><td>Standard deviation</td></tr><tr><td>Systolic blood pressure (mmHg)</td><td>114</td><td>10,0</td></tr><tr><td>Diastolic blood pressure (mmHg)</td><td>69</td><td>10,0</td></tr><tr><td>Estimated GFR (ml/min)</td><td>97,3</td><td>5,8</td></tr><tr><td>Alanine amino-transfe... |
d65a08fb681dc1aca03a5b178be094df5a9d45752ccb720d55566f84b0bca30c.png | complex | <table><tr><td rowspan="2">Macaque (sequence)</td><td rowspan="2">Tissue<sup><i>a</i></sup></td><td rowspan="2">No. of sequences</td><td colspan="2">Genetic diversity (DNAsp)</td><td rowspan="2">Population recombination rate (LDhat), rho</td><td rowspan="2">Molecular adaptation (HyPhy), ω/sites</td><td rowspan="2"... | <table><tr><td rowspan="2">Macaque (sequence)</td><td rowspan="2">Tissuea</td><td rowspan="2">No. of sequences</td><td colspan="2">Genetic diversity (DNAsp)</td><td rowspan="2">Population recombination rate (LDhat), rho</td><td rowspan="2">Molecular adaptation (HyPhy), ω/sites</td><td rowspan="2">Stop codons, N/h</td><... | <table><tr><td rowspan="2">Macaque (sequence)</td><td rowspan="2">Tissuea</td><td rowspan="2">No. of sequences</td><td colspan="2">Genetic diversity (DNAsp)</td><td rowspan="2">Population recombination rate (LDhat), rho</td><td rowspan="2">Molecular adaptation (HyPhy), ω/sites</td><td rowspan="2">Stop codons, N/h</td><... |
d7d04b1713a372623390dffe6b6abe6cf1622ffe9a74ea03de449e436dd43312.png | simple | <table><tr><td>Clone name</td><td>Comment</td></tr><tr><td>Rp11-91k4</td><td>Segmental duplication identified by BLASTN</td></tr><tr><td>Rp11-208g16</td><td>Segmental duplication identified by BLASTN</td></tr><tr><td>Rp11-119l2</td><td>Segmental duplication identified by BLASTN</td></tr><tr><td>RP11-168f7</td><td>Local... | <table><tr><td>Clone name</td><td>Comment</td></tr><tr><td>Rp11-91k4</td><td>Segmental duplication identified by BLASTN</td></tr><tr><td>Rp11-208g16</td><td>Segmental duplication identified by BLASTN</td></tr><tr><td>Rp11-119l2</td><td>Segmental duplication identified by BLASTN</td></tr><tr><td>RP11-168f7</td><td>Local... | <table><tr><td>8</td><td>ion identified by BLASTN</td></tr><tr><td>RP11-129g16</td><td>Misplacement in database; real localization on 3q</td></tr><tr><td>RP11-79o5</td><td>Segmental duplication identified by BLASTN</td></tr><tr><td>RP11-666d14</td><td>Not functioning probe in any experiment</td></tr><tr><td>Rp11-153k19... |
050f6884240f7166216c974871393f0ba979d9511c520b28eb05b9f3363b178c.png | complex | <table><tr><td></td><td colspan="3">Unadjusted models</td><td colspan="3">Adjusted model</td></tr><tr><td></td><td>OR</td><td>95 % CI</td><td><i>p</i> value</td><td>OR</td><td>95 % CI</td><td><i>p</i> value</td></tr><tr><td>Age (years)</td><td>1.07</td><td>1.02 to 1.11</td><td>0.004</td><td></td><td></td><td></td></tr>... | <table><tr><td></td><td colspan="3">Unadjusted models</td><td colspan="3">Adjusted model</td></tr><tr><td></td><td>OR</td><td>95 % CI</td><td>p value</td><td>OR</td><td>95 % CI</td><td>p value</td></tr><tr><td>Age (years)</td><td>1.07</td><td>1.02 to 1.11</td><td>0.004</td><td></td><td></td><td></td></tr><tr><td>IQCODE... | <table><tr><td></td><td colspan="3">Unadjusted models</td><td colspan="3">Adjusted model</td></tr><tr><td></td><td>OR</td><td>95 % CI</td><td>p value</td><td>OR</td><td>95 % CI</td><td>p value</td></tr><tr><td>CSF Neopterin, nmol/La</td><td>3.67</td><td>1.58 to 8.47</td><td>0.002</td><td>3.31</td><td>1.24 to 8.86</td><... |
fc323e528997f92c8c3ad3618fc315a6b3cd901da62da06c1bb42305ec025a85.png | complex | <table><tr><td rowspan="2">Period</td><td colspan="3">O<sub>3</sub></td><td rowspan="2">NO</td><td rowspan="2">NO<sub>2</sub></td><td rowspan="2">NO<sub>X</sub></td><td rowspan="2">O<sub>X</sub></td></tr><tr><td>O<sub>3_mean</sub></td><td>O<sub>3_1-h max</sub></td><td>O<sub>3_8-h max</sub></td></tr><tr><td>2008: 06/01&... | <table><tr><td rowspan="2">Period</td><td colspan="3">O3</td><td rowspan="2">NO</td><td rowspan="2">NO2</td><td rowspan="2">NOX</td><td rowspan="2">OX</td></tr><tr><td>O3_mean</td><td>O3_1-h max</td><td>O3_8-h max</td></tr><tr><td>2008: 06/01–09/30</td><td>75 ± 25</td><td>157 ± 55</td><td>129 ± 46</td><td>5 ± 4</td><td... | <table><tr><td>2010: 06/01–09/30</td><td>53 ± 22</td><td>120 ± 50</td><td>97 ± 42</td><td>6 ± 5</td><td>47 ± 13</td><td>54 ± 14</td><td>100 ± 32</td></tr><tr><td>2011: 06/01–08/10</td><td>79 ± 35</td><td>178 ± 75</td><td>143 ± 64</td><td>4 ± 4</td><td>39 ± 10</td><td>44 ± 12</td><td>118 ± 36</td></tr><tr><td>Mean</td><... |
0e63310c3babecd3bd4b8d6a9854e2651864e02270ef22669f9f2bbc44320cb6.png | simple | <table><tr><td> </td><td>Sum of squares</td><td>df</td><td>Mean square</td><td><i>F</i></td><td><i>P</i></td></tr><tr><td>Between group</td><td>2984.547</td><td>5</td><td>596.909</td><td>1.115</td><td>.359</td></tr><tr><td>Within group</td><td>45,518.750</td><td>85</td><td>535.515</td><td> </td><td> </td></tr><tr><td>T... | <table><tr><td></td></tr><tr><td>Between group</td></tr><tr><td>Within group</td></tr><tr><td>Total</td></tr></table> | <table><tr><td>Sum of squares</td><td>df</td><td>Mean square</td><td>F</td><td>P</td></tr><tr><td>2984.547</td><td>5</td><td>596.909</td><td>1.115</td><td>.359</td></tr><tr><td>45,518.750</td><td>85</td><td>535.515</td><td></td><td></td></tr><tr><td>48,503.297</td><td>90</td><td></td><td></td><td></td></tr></table> |
6aa400f5db796325fb90a8f00749a773ce643bda98d1f31310140c98dccc28e2.png | simple | <table><tr><td></td><td>Field hunting</td><td>Platform</td><td>Open room</td><td>Mantis</td><td>Net hole</td></tr><tr><td>Clutter</td><td><10<sup>−10</sup></td><td><0.00005</td><td>0.58</td><td>0.07</td><td><0.001</td></tr><tr><td>Net hole</td><td><10<sup>−10</sup></td><td><0.00005</td><td>&l... | <table><tr><td></td><td>Field hunting</td><td>Platform</td><td>Open room</td><td>Mantis</td><td>Net hole</td></tr><tr><td>Clutter</td><td><10−10</td><td><0.00005</td><td>0.58</td><td>0.07</td><td><0.001</td></tr><tr><td>Net hole</td><td><10−10</td><td><0.00005</td><td><0.001</td><td>0.33</td><td></td></tr><tr><td>Manti... | <table><tr><td>m</td><td>−10</td><td>05</td><td></td><td></td><td></td></tr><tr><td>Platform</td><td><10−10</td><td></td><td></td><td></td><td></td></tr><tr><td>Field hunting</td><td></td><td></td><td></td><td></td><td></td></tr></table> |
5862eb5cf8efb7022a5d3cc11b0a2add6355907c32e82d1f01641349ed73f9fa.png | complex | <table><tr><td></td><td colspan="3">Allicor</td><td colspan="3">Placebo</td></tr><tr><td>Time</td><td>All</td><td>Men</td><td>Women</td><td>All</td><td>Men</td><td>Women</td></tr><tr><td></td><td>(n = 26)</td><td>(n = 14)</td><td>(n = 12)</td><td>(n = 25)</td><td>(n = 14)</td><td>(n = 11)</td></tr><tr><td colspan="7">A... | <table><tr><td></td><td colspan="3">Allicor</td></tr><tr><td>Time</td><td>All</td><td>Men</td><td>Women</td></tr><tr><td></td><td>(n = 26)</td><td>(n = 14)</td><td>(n = 12)</td></tr><tr><td colspan="4">Absolute risk, %</td></tr><tr><td>At the baseline</td><td>13.1 ± 3.8</td><td>22.3 ± 6.0</td><td>2.3 ± 0.6$</td></tr><t... | <table><tr><td colspan="3">Placebo</td></tr><tr><td>All</td><td>Men</td><td>Women</td></tr><tr><td>(n = 25)</td><td>(n = 14)</td><td>(n = 11)</td></tr><tr><td colspan="3">Absolute risk, %</td></tr><tr><td>8.9 ± 2.4</td><td>14.3 ± 3.7</td><td>2.0 ± 0.7$</td></tr><tr><td>7.8 ± 2.4*</td><td>12.4 ± 3.9*</td><td>1.9 ± 0.6$<... |
d17231e2d99c231301eb87ac5f122dec0d8ce788b53348a2fef042a70e20a78c.png | simple | <table><tr><td>Images</td><td>Training samples</td><td>Testing samples</td><td>Total</td></tr><tr><td>Liver cancer </td><td>40</td><td>40</td><td>80</td></tr><tr><td>Normal cancer</td><td>60</td><td>60</td><td>120</td></tr><tr><td>Liver cirrhosis</td><td>60</td><td>60</td><td>120</td></tr><tr><td>Liver cyst</td><td>60<... | <table><tr><td>Images</td><td>Training samples</td><td>Testing samples</td><td>Total</td></tr><tr><td>Liver cancer</td><td>40</td><td>40</td><td>80</td></tr><tr><td>Normal cancer</td><td>60</td><td>60</td><td>120</td></tr></table> | <table><tr><td>Images</td><td>Training samples</td><td>Testing samples</td><td>Total</td></tr><tr><td>Liver cirrhosis</td><td>60</td><td>60</td><td>120</td></tr><tr><td>Liver cyst</td><td>60</td><td>60</td><td>120</td></tr></table> |
b837490355ba9d2a549dabbec08f6697648df6a965977d26a0d0a1c166c76e33.png | simple | <table><tr><td></td><td>Atrial Fibrillation (AF)*</td><td>Supraventricular tachycardia (SVT)**</td><td>Atrial Flutter***</td><td>Ventricular Ectopics</td></tr><tr><td>Female, n (%)</td><td>7 (28 %)</td><td>5 (20 %)</td><td>2 (8 %)</td><td>1 (4 %)</td></tr><tr><td>Male, n (%)</td><td>7 (28 %)</td><td>0</td><td>3 (12 %)<... | <table><tr><td></td></tr><tr><td>Female, n (%)</td></tr><tr><td>Male, n (%)</td></tr></table> | <table><tr><td>Atrial Fibrillation (AF)*</td><td>Supraventricular tachycardia (SVT)**</td><td>Atrial Flutter***</td><td>Ventricular Ectopics</td></tr><tr><td>7 (28 %)</td><td>5 (20 %)</td><td>2 (8 %)</td><td>1 (4 %)</td></tr><tr><td>7 (28 %)</td><td>0</td><td>3 (12 %)</td><td>0</td></tr></table> |
71c5fdf4564902c6426408b5b8708bcc26af9f570430c831d09391d7ccfa1dad.png | simple | <table><tr><td>No.</td><td>Factor (g/L) </td><td>Low level (-)</td><td>High level (+)</td></tr><tr><td>1</td><td>Isoeugenol</td><td>1</td><td>5</td></tr><tr><td>2</td><td>Dry Biomass</td><td>2.5</td><td>5</td></tr><tr><td>3</td><td>Tween 20</td><td>0</td><td>0.5</td></tr><tr><td>4</td><td>Tween 80</td><td>0</td><td>0.5... | <table><tr><td>No.</td><td>Factor (g/L)</td><td>Low level (-)</td><td>High level (+)</td></tr></table> | <table><tr><td>1</td><td>Isoeugenol</td><td>1</td><td>5</td></tr><tr><td>2</td><td>Dry Biomass</td><td>2.5</td><td>5</td></tr><tr><td>3</td><td>Tween 20</td><td>0</td><td>0.5</td></tr><tr><td>4</td><td>Tween 80</td><td>0</td><td>0.5</td></tr><tr><td>5</td><td>Glycerol</td><td>0</td><td>0.1</td></tr><tr><td>6</td><td>Ye... |
f8a028b19dcb78f3e574458fba33a618fac4acbb0b1aad77ea73ce52eb3e7bf0.png | complex | <table><tr><td>Applications</td><td>Examples</td><td>References</td></tr><tr><td>Oil recovery</td><td>Microbial enhanced oil recovery (MEOR)Increase amount of recoverable oil aided by rhamnolipid-producing microorganisms</td><td>[73][2, 74]</td></tr><tr><td rowspan="3">Bioremediation</td><td>Bioremediation of petroleum... | <table><tr><td>Applications</td><td>Examples</td><td>References</td></tr><tr><td>Oil recovery</td><td>Microbial enhanced oil recovery (MEOR)Increase amount of recoverable oil aided by rhamnolipid-producing microorganisms</td><td>[73][2, 74]</td></tr><tr><td rowspan="3">Bioremediation</td><td>Bioremediation of petroleum... | <table><tr><td rowspan="2">Crop protection</td><td>As biocontrol agent against several phytopathogenic fungi; addition of rhamnolipids or rhamnolipid-containing cell-free broth are effective in inhibiting growth of phytopathogens, e.g. F. oxysporum, B. cinerea, Mucor spp. and many more</td><td>[1, 7, 81–84]</td></tr><t... |
0fe76d3bcd7df10b6f8525eb60cf5b42b49140aa31bfab4bb8a975a28e661976.png | complex | <table><tr><td rowspan="2">Parameters</td><td colspan="2">Anemic patients</td><td colspan="2">Non-anemic patients</td></tr><tr><td>N</td><td>Number (%) or mean ± SD</td><td>N</td><td>Number (%) or mean ± SD</td></tr><tr><td>Demographics</td><td></td><td></td><td></td><td></td></tr><tr><td>Age, years</td><td>1... | <table><tr><td rowspan="2">Parameters</td><td colspan="2">Anemic patients</td><td colspan="2">Non-anemic patients</td></tr><tr><td>N</td><td>Number (%) or mean ± SD</td><td>N</td><td>Number (%) or mean ± SD</td></tr><tr><td>Demographics</td><td></td><td></td><td></td><td></td></tr><tr><td>Age, years</td><td>162</td><td... | <table><tr><td rowspan="2">Parameters</td><td colspan="2">Anemic patients</td><td colspan="2">Non-anemic patients</td></tr><tr><td>N</td><td>Number (%) or mean ± SD</td><td>N</td><td>Number (%) or mean ± SD</td></tr><tr><td>ace</td><td></td><td></td><td></td><td></td></tr><tr><td>Chinese/Malay/Indian/Others</td><td>162... |
a71e5b811954466a979ed95d0e647fec5e93a3c8a6ead5c7e10cf8468ede6a2e.png | complex | <table><tr><td colspan="2">Variables</td><td>N (%)</td></tr><tr><td rowspan="2">Sex</td><td>Female</td><td>16 (34.8%)</td></tr><tr><td>Male</td><td>30 (65.2%)</td></tr><tr><td rowspan="2">Age 30.5 ± 6.9 (mean ± SD)</td><td>23–28 year</td><td>26 (56.5%)</td></tr><tr><td>29–51 year</td><td>20 (43.5%... | <table><tr><td colspan="2">Variables</td><td>N (%)</td></tr><tr><td rowspan="2">Sex</td><td>Female</td><td>16 (34.8%)</td></tr><tr><td>Male</td><td>30 (65.2%)</td></tr><tr><td rowspan="2">Age 30.5 ± 6.9 (mean ± SD)</td><td>23–28 year</td><td>26 (56.5%)</td></tr><tr><td>29–51 year</td><td>20 (43.5%)</td></tr><tr><td row... | <table><tr><td rowspan="2">Additional work experience</td><td>Yes</td><td>18 (39.1%)</td></tr><tr><td>No</td><td>28 (60.9%)</td></tr><tr><td rowspan="2">Employment status</td><td>Owner</td><td>18 (39.1%)</td></tr><tr><td>Employee</td><td>28 (60.9%)</td></tr><tr><td rowspan="2">Membership to any professional organizatio... |
99b84a1fc170680f6ade57fbcaba32eb71544e9fbed83dd406fa268036270a73.png | simple | <table><tr><td>Treatment</td><td>COC</td><td>GV</td><td>GVBD</td><td>MI</td><td>MII</td></tr><tr><td> </td><td>(n)</td><td>(%)</td><td>(%)</td><td>(%)</td><td>(%)</td></tr><tr><td><i>SOF</i></td><td>75</td><td>11/78 (14.6)</td><td>9/75 (12.0)</td><td>14/75 (18.7)</td><td>41/75 (54.7)</td></tr><tr><td><i>SOF + GM-CSF (1... | <table><tr><td>Treatment</td><td>COC</td><td>GV</td><td>GVBD</td><td>MI</td></tr><tr><td></td><td>(n)</td><td>(%)</td><td>(%)</td><td>(%)</td></tr><tr><td>SOF</td><td>75</td><td>11/78 (14.6)</td><td>9/75 (12.0)</td><td>14/75 (18.7)</td></tr><tr><td>SOF + GM-CSF (1 ng/ml)</td><td>71</td><td>11/71 (15.5)</td><td>5/71 (7.... | <table><tr><td>MII</td></tr><tr><td>(%)</td></tr><tr><td>41/75 (54.7)</td></tr><tr><td>42/71 (59.2)</td></tr><tr><td>32/59 (54.2)</td></tr><tr><td>53/89 (59.6)</td></tr><tr><td>79/95 (83.2*)</td></tr></table> |
1019e774c572d66a4b254207f9dbc5d0ac230eaba7eeaf1d317db3551ce448a4.png | complex | <table><tr><td>Sl. No:</td><td>Factors</td><td>Level description</td><td>Level</td><td>Contribution</td></tr><tr><td>1</td><td>Temperature (°C)</td><td>28</td><td>2</td><td>0.025</td></tr><tr><td>2</td><td>pH</td><td>5</td><td>2</td><td>0.081</td></tr><tr><td>3</td><td>Galactose (%)</td><td>0.8</td><td>1</td><td>0... | <table><tr><td>Sl. No:</td><td>Factors</td><td>Level description</td><td>Level</td><td>Contribution</td></tr><tr><td>1</td><td>Temperature (°C)</td><td>28</td><td>2</td><td>0.025</td></tr><tr><td>2</td><td>pH</td><td>5</td><td>2</td><td>0.081</td></tr><tr><td>3</td><td>Galactose (%)</td><td>0.8</td><td>1</td><td>0.223<... | <table><tr><td colspan="4">erage of performance</td><td>54.743</td></tr><tr><td colspan="4">Expected result at optimum condition</td><td>56.769</td></tr></table> |
bb2f26dcf6d4151603d5dbb0da486bec6eb438c7bc22688aef37dbc07985fe42.png | complex | <table><tr><td rowspan="2">Variable (number of patients evaluated)</td><td rowspan="2"></td><td colspan="2">PD-L1 expression</td><td rowspan="2"><i>p</i>-value</td></tr><tr><td>Positive</td><td>Negative</td></tr><tr><td>Tumor stage (99)</td><td>High</td><td>2</td><td>14</td><td>0.66</td></tr><tr><td></td><td>Low</td><t... | <table><tr><td rowspan="2">Variable (number of patients evaluated)</td><td rowspan="2"></td><td colspan="2">PD-L1 expression</td><td rowspan="2">p-value</td></tr><tr><td>Positive</td><td>Negative</td></tr><tr><td>Tumor stage (99)</td><td>High</td><td>2</td><td>14</td><td>0.66</td></tr><tr><td></td><td>Low</td><td>8</td... | <table><tr><td rowspan="2">Variable (number of patients evaluated)</td><td rowspan="2"></td><td colspan="2">PD-L1 expression</td><td rowspan="2">p-value</td></tr><tr><td>Positive</td><td>Negative</td></tr><tr><td>Tumor grade (102)</td><td>High</td><td>9</td><td>81</td><td>1.00</td></tr><tr><td></td><td>Low</td><td>1</t... |
175db5d915a086e864b1e266c6d28511240fa5a1c0151c5b8f95400cba890477.png | complex | <table><tr><td> </td><td>EW</td><td>DW</td><td>p</td></tr><tr><td>n (%)</td><td>80 (79.2%)</td><td>21 (20.8%)</td><td> </td></tr><tr><td rowspan="2">GA, mean ± SD (range), wk</td><td>30.3 ± 2.5</td><td>27.5 ± 2.1</td><td rowspan="2">< 0.0001</td></tr><tr><td>(24 – 35)</td><td>(23 – 31)</td... | <table><tr><td></td><td>EW</td><td>DW</td><td>p</td></tr><tr><td>n (%)</td><td>80 (79.2%)</td><td>21 (20.8%)</td><td></td></tr><tr><td>GA, mea</td><td>30.3 ± </td><td></td><td>< 0</td></tr></table> | <table><tr><td rowspan="2">n ± SD (range), wk</td><td>2.5</td><td>27.5 ± 2.1</td><td rowspan="2">.0001</td></tr><tr><td>(24 – 35)</td><td>(23 – 31)</td></tr><tr><td rowspan="2">BW, mean ± SD (range), g</td><td>1198 ± 270</td><td>894 ± 251</td><td rowspan="2">< 0.0001</td></tr><tr><td>(450 – 1590)</td><td>(475 – 1520)</... |
ea517555285dc8f7aa4870a946e6be631def44602f4abc6a4dfddb06bf543501.png | simple | <table><tr><td>Study </td><td>Asthma therapy</td><td>Number of subjects</td><td>Results </td></tr><tr><td>Farah et al., 2011 [36]</td><td>Fluticasone/salmeterol</td><td>49</td><td>Similar improvements in asthma control, spirometry, airway inflammation, and airway hyperresponsiveness across BMI groups</td></tr><tr><td>S... | <table><tr><td>Study</td><td>Asthma therapy</td><td>Number of subjects</td><td>Results</td></tr><tr><td>Farah et al., 2011 [36]</td><td>Fluticasone/salmeterol</td><td>49</td><td>Similar improvements in asthma control, spirometry, airway inflammation, and airway hyperresponsiveness across BMI groups</td></tr><tr><td>Sut... | <table><tr><td>Study</td><td>Asthma therapy</td><td>Number of subjects</td><td>Results</td></tr><tr><td>rland et al., 2010 [46]</td><td>ticasone, montelukast</td><td>52</td><td>e greater improvement across all BMI categories when compared to montelukast</td></tr><tr><td>Sutherland et al., 2008 [37]</td><td>Glucocortico... |
8bb91cc2f1b8c6c803ac73c3a407708bd863813a01fe78ad467e8f5605dcafbf.png | simple | <table><tr><td>Quantity</td><td>Value</td><td>Description</td></tr><tr><td><i>z</i><sub>1</sub></td><td>8 mm</td><td>Distance between the stem and the point light source [12]</td></tr><tr><td><i>z</i><sub>2</sub></td><td>297 mm</td><td>Distance between the stem and the screen [12]</td></tr><tr><td>Δ<i>x</i></td><t... | <table><tr><td>Quantity</td></tr><tr><td>z1</td></tr><tr><td>z2</td></tr><tr><td>Δx</td></tr><tr><td>Δp</td></tr><tr><td>N</td></tr><tr><td>C</td></tr></table> | <table><tr><td>Value</td><td>Description</td></tr><tr><td>8 mm</td><td>Distance between the stem and the point light source [12]</td></tr><tr><td>297 mm</td><td>Distance between the stem and the screen [12]</td></tr><tr><td>229 mm (for the stem width = 6 mm)</td><td>Width of the geometrical shadow [12]</td></tr><tr><td... |
a0fbb8b03bf767aafd2b19257d2043532439a0d6fe07a27f2dd6574b6be07a4a.png | complex | <table><tr><td rowspan="3">Age</td><td colspan="2">women with breast cancer</td></tr><tr><td>n</td><td>%</td></tr><tr><td>≤30</td><td>4</td><td>4.0</td></tr><tr><td>31-49</td><td>43</td><td>43.0</td></tr><tr><td>50-59</td><td>32</td><td>32.0</td></tr><tr><td>60-69</td><td>13</td><td>13.0</td></tr><tr><td>≥7... | <table><tr><td rowspan="3">Age</td><td colspan="2">women with breast cancer</td></tr><tr><td>n</td><td>%</td></tr><tr><td colspan="2"></td></tr></table> | <table><tr><td></td><td colspan="2"></td></tr><tr><td>≤30</td><td>4</td><td>4.0</td></tr><tr><td>31-49</td><td>43</td><td>43.0</td></tr><tr><td>50-59</td><td>32</td><td>32.0</td></tr><tr><td>60-69</td><td>13</td><td>13.0</td></tr><tr><td>≥70</td><td>8</td><td>8.0</td></tr><tr><td>Total</td><td>100</td><td>100.0</td></t... |
266f1f360f6eb7dd3ca5d3312f5ff66c4442fc390d15b46e47aa19ce32a71a2f.png | simple | <table><tr><td>ID</td><td>Farm</td><td>Age (months)</td><td>Sex</td><td>Weight (kg)</td><td>Previous episodes of BRD</td><td>Spontaneous cough</td><td>Nasal discharge</td><td>Abnormal lung sounds</td><td>Read number NS sample</td><td>Read number TTA sample</td></tr><tr><td>1<sup>a</sup></td><td>TO1</td><td>14</td><td>M... | <table><tr><td>ID</td><td>Farm</td><td>Age (months)</td><td>Sex</td><td>Weight (kg)</td><td>Previous episodes of BRD</td><td>Spontaneous cough</td><td>Nasal discharge</td><td>Abnormal lung sounds</td><td>Read number NS sample</td><td>Read number TTA sample</td></tr><tr><td>1a</td><td>TO1</td><td>14</td><td>M</td><td>40... | <table><tr><td>18b</td><td>TO2</td><td>6</td><td>M</td><td>200</td><td>No</td><td>Absent</td><td>Absent</td><td>Absent</td><td>3932</td><td>55,630</td></tr><tr><td>19b</td><td>TO2</td><td>6</td><td>M</td><td>200</td><td>No</td><td>Absent</td><td>Absent</td><td>Absent</td><td>DNA < 5 ng/μl</td><td>1,825c</td></tr><tr><t... |
bfb4489cf7acd4c586d7f86224c8368aa28ae7605d3d6b1ae4e998d1f910ecc3.png | simple | <table><tr><td>CombinedPrograms</td><td>Single Program</td><td>t-value</td><td>Single Program</td><td>t-value</td></tr><tr><td>USR + GZD</td><td>USR</td><td><underline>1.414</underline></td><td>GZD</td><td>0.150</td></tr><tr><td>USR + PS</td><td>USR</td><td><underline>1.373</underline></td><td>PS</td><td><underline>1.3... | <table><tr><td>CombinedPrograms</td></tr><tr><td>USR + GZD</td></tr><tr><td>USR + PS</td></tr><tr><td>USR + ROCS</td></tr><tr><td>GZD + PS</td></tr><tr><td>GZD + ROCS</td></tr><tr><td>PS + ROCS</td></tr></table> | <table><tr><td>Single Program</td><td>t-value</td><td>Single Program</td><td>t-value</td></tr><tr><td>USR</td><td>1.414</td><td>GZD</td><td>0.150</td></tr><tr><td>USR</td><td>1.373</td><td>PS</td><td>1.369</td></tr><tr><td>USR</td><td>2.489</td><td>ROCS</td><td>1.409</td></tr><tr><td>GZD</td><td>1.409</td><td>PS</td><t... |
5197a892f374bc768731a04fe3e3a82727298c0bcd784a2df770f6f2100d4f5a.png | simple | <table><tr><td>S.No.</td><td>Angiogenesis analyzer parameter</td><td>FRG1 overexpression vector</td><td>Control vector</td><td><i>P-</i>value</td></tr><tr><td>1</td><td>Number of extremities</td><td>132 ± 25</td><td>107 ± 14</td><td>0.026</td></tr><tr><td>2</td><td>Number of nodes</td><td>263 ± 98</td><t... | <table><tr><td>S.No.</td><td>Angiogenesis analyzer parameter</td><td>FRG1 overexpression vector</td><td>Control vector</td><td>P-value</td></tr><tr><td>1</td><td>Number of extremities</td><td>132 ± 25</td><td>107 ± 14</td><td>0.026</td></tr><tr><td>2</td><td>Number of nodes</td><td>263 ± 98</td><td>371 ± 96</td><td>0.0... | <table><tr><td>19</td><td>Mesh index</td><td>200 ± 26</td><td>212 ± 28</td><td>0.22</td></tr><tr><td>20</td><td>Mean mesh size</td><td>6830 ± 1740</td><td>10358 ± 3523</td><td>0.024</td></tr></table> |
e990db6677ee9edb32a9700a9b7bccc04a9cd7cabb53863af357fac77ffda211.png | complex | <table><tr><td><i>cis</i>-element</td><td>Position (From ATG)</td><td>Sequence (5′-3′)</td></tr><tr><td colspan="3">Light regulation elements</td></tr><tr><td> 3-AF1 binding site</td><td>−1444(+)</td><td>ATGAGATATTT</td></tr><tr><td> ACE</td><td>−1387(−)</td><td>CAAACGTATT</td></tr><tr><td... | <table><tr><td>cis-element</td></tr><tr><td>Light regulation elements</td></tr><tr><td>3-AF1 binding site</td></tr><tr><td>ACE</td></tr><tr><td>AT1-motif</td></tr><tr><td>Box 4</td></tr><tr><td>Box I</td></tr><tr><td>G-Box</td></tr><tr><td>I-box</td></tr><tr><td>LAMP-element</td></tr><tr><td>chs-CMA1a</td></tr><tr><td>... | <table><tr><td>Position (From ATG)</td><td>Sequence (5′-3′)</td></tr><tr><td colspan="2">Light regulation elements</td></tr><tr><td>−1444(+)</td><td>ATGAGATATTT</td></tr><tr><td>−1387(−)</td><td>CAAACGTATT</td></tr><tr><td>−511(+)</td><td>AATTATTATTTATT</td></tr><tr><td>−126(+),−560(+),−615(+),−752(+),−1183(+)</td><td>... |
719926668a6e33415eccf9fa9fab1da857e02ba76d8bb5c47f7d377f23e48794.png | complex | <table><tr><td></td><td colspan="2">Dentistry (<i>N</i> = 31)</td><td colspan="2">Health Sciences (<i>N</i> = 22)</td><td colspan="2">Pharmacy (<i>N</i> = 28)</td></tr><tr><td>Items</td><td>Mean</td><td>Agreement (%)</td><td>Mean</td><td>Agreement (%)</td><td>Mean</td><td>Agreement (%)</td></tr><tr><td>Q3_well_organize... | <table><tr><td></td><td colspan="2">Dentistry (N = 31)</td><td colspan="2">Health Sciences (N = 22)</td><td colspan="2">Pharmacy (N = 28)</td></tr><tr><td>Items</td><td>Mean</td><td>Agreement (%)</td><td>Mean</td><td>Agreement (%)</td><td>Mean</td><td>Agreement (%)</td></tr><tr><td>Q3_well_organized</td><td>3.14</td><t... | <table><tr><td></td><td colspan="2">Dentistry (N = 31)</td><td colspan="2">Health Sciences (N = 22)</td><td colspan="2">Pharmacy (N = 28)</td></tr><tr><td>Items</td><td>Mean</td><td>Agreement (%)</td><td>Mean</td><td>Agreement (%)</td><td>Mean</td><td>Agreement (%)</td></tr><tr><td>Q4_safe_environment*</td><td>3.34</td... |
18f7aee53c5a515de5f8d4c929e77dd8f78f0cfaaf08f1137c784cc80b270c36.png | complex | <table><tr><td>Focus of Review</td><td colspan="4">Methodological Rating</td></tr><tr><td></td><td>Strong</td><td>Moderate</td><td>Weak</td><td>Total</td></tr><tr><td>Chronic Diseases (All)</td><td><i>329</i></td><td><i>144</i></td><td><i>141</i></td><td>614</td></tr><tr><td>Adult Health (All)</td><td><i>244</i></td><t... | <table><tr><td>Focus of Review</td><td colspan="4">Methodological Rating</td></tr><tr><td></td><td>Strong</td><td>Moderate</td><td>Weak</td><td>Total</td></tr><tr><td>Chronic Diseases (All)</td><td>329</td><td>144</td><td>141</td><td>614</td></tr><tr><td>Adult Health (All)</td><td>244</td><td>117</td><td>98</td><td>459... | <table><tr><td>Senior Health (All)</td><td>84</td><td>27</td><td>22</td><td>133</td></tr><tr><td>Healthy Communities (All)</td><td>43</td><td>26</td><td>29</td><td>98</td></tr><tr><td>Environmental Health (All)</td><td>39</td><td>10</td><td>14</td><td>63</td></tr><tr><td>Social Determinants of Health (All)</td><td>30</... |
64fccdce6feaf47d9da9307fc780bda030e210f18ec176bdc95f9e77c003f55c.png | complex | <table><tr><td>Concentrations of Paclitaxel (nM)</td><td colspan="2">BIM/GAPDH</td><td colspan="2">PTEN/GAPDH</td></tr><tr><td></td><td>m-PTIP-GFP</td><td>m-PTIP-Sponge all</td><td>m-PTIP-GFP</td><td>m-PTIP-Sponge all</td></tr><tr><td>0</td><td>70.59 ± 3.4215</td><td>107.70 ± 2.3265 *</td><td>122.77 ± 2.... | <table><tr><td>Concentrations of Paclitaxel (nM)</td><td colspan="2">BIM/GAPDH</td><td colspan="2">PTEN/GAPDH</td></tr><tr><td></td><td>m-PTIP-GFP</td><td>m-PTIP-Sponge all</td><td>m-PTIP-GFP</td><td>m-PTIP-Sponge all</td></tr><tr><td>0</td><td>70.59 ± 3.4215</td><td>107.70 ± 2.3265 *</td><td>122.77 ± 2.3265</td><td>13... | <table><tr><td>200</td><td>109.54 ± 1.1399</td><td>164.46 ± 3.7326 *</td><td>116.54 ± 1.3357</td><td>125.28 ± 3.2158</td></tr></table> |
9efcccc857bf94b01b8c5073e833f58d5475a6bd375511591997cb7c2dd178e9.png | complex | <table><tr><td>Outcome measures</td><td>Operationalisation</td><td colspan="3">Measurement</td></tr><tr><td> </td><td> </td><td>SCR</td><td>Qt</td><td>TIp</td></tr><tr><td><i>Usefulness</i></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Population reached</td><td>General characteristics of the participants an... | <table><tr><td>Outcome measures</td><td>Operationalisation</td><td>Measurement</td></tr><tr><td></td><td></td><td>SCR</td></tr><tr><td>Usefulness</td><td></td><td></td></tr><tr><td>Population reached</td><td>General characteristics of the participants and trainers</td><td>+</td></tr><tr><td></td><td>Target population a... | <table><tr><td colspan="2">Measurement</td></tr><tr><td>Qt</td><td>TIp</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td>+</td><td></td></tr><tr><td>+</td><td></td></tr><tr><td>+</td><td></td></tr><tr><td></td><td>+</td></tr><tr><td>+</td><td>+</td></tr><tr><td>+</td><td></td></tr><tr><td>+</td><td... |
37a63fa171a98fe457fe14c0c3e5ae1f45802499a32b0705b8b26fda7d477f37.png | complex | <table><tr><td colspan="5">HCV-1</td><td colspan="5">HCV-2</td></tr><tr><td>SNP ID</td><td>SVR (+)</td><td>SVR (−)</td><td><i>P</i></td><td>OR (95% CI)</td><td>SNP ID</td><td>SVR (+)</td><td>SVR (−)</td><td><i>P</i></td><td>OR (95% CI)</td></tr><tr><td> </td><td>N (%)</td><td>N (%)</td><td> </td><td> </td><... | <table><tr><td colspan="5">HCV-1</td><td colspan="3">HCV-2</td></tr><tr><td>SNP ID</td><td>SVR (+)</td><td>SVR (−)</td><td>P</td><td>OR (95% CI)</td><td>SNP ID</td><td>SVR (+)</td><td>SVR (−)</td></tr><tr><td></td><td>N (%)</td><td>N (%)</td><td></td><td></td><td></td><td>N (%)</td><td>N (%)</td></tr><tr><td colspan="5... | <table><tr><td colspan="2">HCV-2</td></tr><tr><td>P</td><td>OR (95% CI)</td></tr><tr><td></td><td></td></tr><tr><td colspan="2">rs1059513</td></tr><tr><td></td><td>0.90 (0.20, 4.01)</td></tr><tr><td>0.8954</td><td>1</td></tr><tr><td colspan="2">rs703817</td></tr><tr><td></td><td>2.05 (0.77, 5.45)</td></tr><tr><td>0.142... |
0b76aecb64a63849ad2277041c226f95a12e1a4fb59e1645c7ac187a60b729d6.png | simple | <table><tr><td></td><td>Heart Health Program</td><td>Traditional Hospital Cardiac Programs</td></tr><tr><td>Referral</td><td>No formal process, mostly word of mouth or opportunistic due to location.</td><td>Formal referral from doctor or cardiac nurse post cardiac event.</td></tr><tr><td>Attendance</td><td>As often as ... | <table><tr><td></td><td>Heart Health Program</td><td>Traditional Hospital Cardiac Programs</td></tr><tr><td>Referral</td><td>No formal process, mostly word of mouth or opportunistic due to location.</td><td>Formal referral from doctor or cardiac nurse post cardiac event.</td></tr><tr><td>Attendance</td><td>As often as ... | <table><tr><td>Transport</td><td>Provided to anyone who requires it at no cost.</td><td>Make own arrangements.</td></tr><tr><td>Food</td><td>Morning tea and lunch provided.</td><td>Not provided.</td></tr><tr><td>Exercise</td><td>Group walk and exercise-physiologist led rehabilitation exercises (walk pending weather).</... |
01d301e8e068602d9e87dd7cb7d69cb931005b96610e02f6205bce3a62ecfd2c.png | simple | <table><tr><td></td><td>Lost to Follow-up N (%)</td><td>Completed Follow-up N (%)</td><td>RR (95% CI)</td></tr><tr><td>Lost to Follow-up Status After Delivery, N</td><td>1,385</td><td>277,733</td><td></td></tr><tr><td>Delivery location</td><td></td><td></td><td></td></tr><tr><td>Hospital</td><td>451 (33.3)</td><td>126,... | <table><tr><td></td><td>Lost to Follow-up N (%)</td></tr><tr><td>Lost to Follow-up Status After Delivery, N</td><td>1,385</td></tr><tr><td>Delivery location</td><td></td></tr><tr><td>Hospital</td><td>451 (33.3)</td></tr><tr><td>Clinic</td><td>394 (29.1)</td></tr><tr><td>Home/Other</td><td>508 (37.5)</td></tr><tr><td>De... | <table><tr><td>Completed Follow-up N (%)</td><td>RR (95% CI)</td></tr><tr><td>277,733</td><td></td></tr><tr><td></td><td></td></tr><tr><td>126,606 (45.6)</td><td>1.0</td></tr><tr><td>68,689 (24.7)</td><td>1.1 (1.0, 1.3)</td></tr><tr><td>82,303 (29.6)</td><td>1.0 (0.8, 1.1)</td></tr><tr><td></td><td></td></tr><tr><td>23... |
b60ecb91b4f51bd88e299a24e30c0622431745dba9555a9cd1cf587ed7475fdb.png | complex | <table><tr><td rowspan="3"></td><td>Participated in FW (<i>n</i> = 2835)</td></tr><tr><td>(Reference category: Did not participate in FW)</td></tr><tr><td>OR (95% CI)</td></tr><tr><td colspan="2">Demographics</td></tr><tr><td colspan="2">Sex</td></tr><tr><td>Man</td><td>1.00</td></tr><tr><td>Woman</td><td>0.92 (0.76... | <table><tr><td rowspan="3"></td><td>Participated in FW (n = 2835)</td></tr><tr><td>(Reference category: Did not participate in FW)</td></tr><tr><td>OR (95% CI)</td></tr><tr><td colspan="2">Demographics</td></tr><tr><td colspan="2">Sex</td></tr><tr><td>Man</td><td>1.00</td></tr><tr><td>Woman</td><td>0.92 (0.76–1.13)</td... | <table><tr><td>n</td><td>(0.23–0.56)***</td></tr><tr><td colspan="2">Educational institution</td></tr><tr><td>Not business school</td><td>1.00</td></tr><tr><td>Business school</td><td>1.60 (1.23–2.08)***</td></tr><tr><td colspan="2">Personality</td></tr><tr><td>ExtroversionZ</td><td>1.18 (1.07–1.29)**</td></tr><tr><td>... |
d10a73a719e54c4d20341d148008bcb892ec1b84e785bff2424a9e2c22e3b21c.png | simple | <table><tr><td>Antibody</td><td>Identification</td><td>Dilution</td><td>Source</td></tr><tr><td>p16INK4a</td><td>E6H4</td><td>undiluted</td><td>mtm laboratories AG, Heidelberg, Germany</td></tr><tr><td>MMP-7</td><td>Clone ID2</td><td>1:30</td><td>Calbiochem, Merck Chemicals Ltd., Nottingham, UK</td></tr><tr><td>MMP-12<... | <table><tr><td>Antibody</td><td>Identification</td><td>Dilution</td><td>Source</td></tr><tr><td>p16INK4a</td><td>E6H4</td><td>undiluted</td><td>mtm laboratories AG, Heidelberg, Germany</td></tr><tr><td>MMP-7</td><td>Clone ID2</td><td>1:30</td><td>Calbiochem, Merck Chemicals Ltd., Nottingham, UK</td></tr><tr><td>MMP-12<... | <table><tr><td>N-cadherin</td><td>Clone GC-4</td><td>1:30</td><td>Sigma-Aldrich Inc., Saint Louis, MO</td></tr><tr><td>Beta-catenin</td><td>Clone 14</td><td>1:30</td><td>BD Transduction Laboratories, Franklin Lakes, NJ</td></tr></table> |
2cd0d1a30cc1ceea4063fcb89a19ede1daf43bdf97b3a7811cb176ded183d3e8.png | complex | <table><tr><td rowspan="3">Dopant</td><td colspan="6">SnO<sub>2</sub>–d (110) in Å</td></tr><tr><td rowspan="2">Urea</td><td rowspan="2">Ammonia</td><td colspan="2">Chemically Doped</td><td colspan="2">Impregnated Powders</td></tr><tr><td>Urea</td><td>Ammonia</td><td>Urea</td><td>Ammonia</td></tr><tr><td>Un... | <table><tr><td rowspan="3">Dopant</td><td colspan="6">SnO2–d (110) in Å</td></tr><tr><td rowspan="2">Urea</td><td rowspan="2">Ammonia</td><td colspan="2">Chemically Doped</td><td colspan="2">Impregnated Powders</td></tr><tr><td>Urea</td><td>Ammonia</td><td>Urea</td><td>Ammonia</td></tr></table> | <table><tr><td>Undoped</td><td>3.35853</td><td>3.35492</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Cu</td><td>-</td><td>-</td><td>3.3732</td><td>3.36927</td><td>3.3682</td><td>3.3927</td></tr><tr><td>Pt</td><td>-</td><td>-</td><td>3.39422</td><td>3.38839</td><td>3.3801</td><td>3.35427</td></tr><tr><td>Pd</... |
f09534c384c6c683ff2be239f54d83d3cb2337789e026fc822694737e0987115.png | complex | <table><tr><td>Reference, Study Location and data collection period</td><td>Study Design Subject Characteristics and sample size</td><td>Exposure air pollutants</td><td>Health outcomes</td><td>Results</td><td>Adjustment for confounding factors</td><td>Limitations</td></tr><tr><td colspan="7">Cross sectional studies</td... | <table><tr><td>Reference, Study Location and data collection period</td><td>Study Design Subject Characteristics and sample size</td><td>Exposure air pollutants</td><td>Health outcomes</td><td>Results</td><td>Adjustment for confounding factors</td><td>Limitations</td></tr><tr><td colspan="7">Cross sectional studies</td... | <table><tr><td>Reference, Study Location and data collection period</td><td>Study Design Subject Characteristics and sample size</td><td>Exposure air pollutants</td><td>Health outcomes</td><td>Results</td><td>Adjustment for confounding factors</td><td>Limitations</td></tr><tr><td></td><td>n = 441);non asthmatics (n = 1... |
a38433e65bd11825e6a8b5cdb9056f7e2a11d4f6993d56d3e1e60dc8d320dae9.png | complex | <table><tr><td rowspan="2">Cropping system cultivar</td><td>Organic</td><td>Conventional</td><td>Average</td><td>Difference in organic</td></tr><tr><td>Mg ha<sup>−1</sup></td><td>Mg ha<sup>−1</sup></td><td> Mg ha<sup>−1</sup></td><td>%</td></tr><tr><td>Matt</td><td>2.13</td><td>2.85</td><td>2.48 b</td... | <table><tr><td rowspan="2">Cropping system cultivar</td><td>Organic</td><td>Conventional</td><td>Average</td><td>Difference in organic</td></tr><tr><td>Mg ha−1</td><td>Mg ha−1</td><td>Mg ha−1</td><td>%</td></tr><tr><td>Matt</td><td>2.13</td><td>2.85</td><td>2.48 b</td><td>−25.0</td></tr><tr><td>Saragolla</td><td>3.62</... | <table><tr><td rowspan="2">Cropping system cultivar</td><td>Organic</td><td>Conventional</td><td>Average</td><td>Difference in organic</td></tr><tr><td>Mg ha−1</td><td>Mg ha−1</td><td>Mg ha−1</td><td>%</td></tr><tr><td>Average</td><td>2.52 b</td><td>3.23 a</td><td>2.87</td><td>−21.0</td></tr></table> |
cb058088a4c4f9db98d906aaf0d8b39f8e7e67729cb21cbb24de4e8325ee7c2d.png | simple | <table><tr><td>Demographics</td><td></td><td></td></tr><tr><td>Age (yrs) (mean ± SD)</td><td></td><td>65.8 ± 8.7</td></tr><tr><td>

</td><td></td><td></td></tr><tr><td>Male/Female</td><td></td><td>46%/54%</td></tr><tr><td>

</td><td></td><td></td></tr><tr><td>Wealth (%)</td><td></td><t... | <table><tr><td>Demographics</td><td></td><td></td></tr><tr><td>Age (yrs) (mean ± SD)</td><td></td><td>65.8 ± 8.7</td></tr><tr><td></td><td></td><td></td></tr><tr><td>Male/Female</td><td></td><td>46%/54%</td></tr><tr><td></td><td></td><td></td></tr><tr><td>Wealth (%)</td><td></td><td></td></tr><tr><td></td><td>Poorest t... | <table><tr><td>Demographics</td><td></td><td></td></tr><tr><td>Depression at 4-year follow-up</td><td></td><td>10%</td></tr><tr><td></td><td></td><td></td></tr><tr><td>DHEA(S) (μmol/L) (mean ± SD)</td><td></td><td>2.41 ± 1.80</td></tr></table> |
bfcc305cea02cc38f90f31df16555bb210f3b0da6bd298b3364a9b6e1750c502.png | complex | <table><tr><td></td><td></td><td colspan="3">Vascular plants</td><td colspan="3">Bryophytes</td></tr><tr><td></td><td></td><td><i>F</i>-value</td><td><i>P</i>-value</td><td><i>r</i></td><td><i>F</i>-value</td><td><i>P</i>-value</td><td><i>r</i></td></tr><tr><td>MAT</td><td>Plant community</td><td>1.3</td><td>0.26</td><... | <table><tr><td></td><td></td><td colspan="3">Vascular plants</td><td colspan="3">Bryophytes</td></tr><tr><td></td><td></td><td>F-value</td><td>P-value</td><td>r</td><td>F-value</td><td>P-value</td><td>r</td></tr><tr><td>MAT</td><td>Plant community</td><td>1.3</td><td>0.26</td><td>−0.07</td><td>1.5</td><td>0.23</td><td>... | <table><tr><td></td><td>Cluster II</td><td>11.4</td><td>≤0.001</td><td>0.41</td><td>3.7</td><td>0.06</td><td>0.22</td></tr><tr><td>TS</td><td>Plant community</td><td>0.0</td><td>0.83</td><td>0.13</td><td>6.2</td><td>≤0.01</td><td>0.29</td></tr><tr><td></td><td>Cluster I</td><td>29.0</td><td>≤0.001</td><td>0.59</td><td>... |
22e8ff2243da845f736daa32fec816dbc1e2cb17b3745284952c82577a767c9e.png | complex | <table><tr><td>Treatment Effect</td><td>Control Exacerbation Rate (per‐person year)</td><td>AAR</td><td>ERT</td></tr><tr><td rowspan="3">0.5</td><td>1.3</td><td>0.82</td><td>0.83</td></tr><tr><td>1.8</td><td>0.87</td><td>0.88</td></tr><tr><td>2.3</td><td>0.89</td><td>0.91</td></tr><tr><td rowspan="3">0.7</td><td>... | <table><tr><td>Treatment Effect</td><td>Control Exacerbation Rate (per‐person year)</td><td>AAR</td><td>ERT</td></tr><tr><td rowspan="3">0.5</td><td>1.3</td><td>0.82</td><td>0.83</td></tr><tr><td>1.8</td><td>0.87</td><td>0.88</td></tr><tr><td>2.3</td><td>0.89</td><td>0.91</td></tr><tr><td rowspan="3">0.7</td><td>1.3</t... | <table><tr><td>Treatment Effect</td><td>Control Exacerbation Rate (per‐person year)</td><td>AAR</td><td>ERT</td></tr><tr><td>1.5</td><td>2.3</td><td>0.52</td><td>0.56</td></tr></table> |
408b4c55fce789f302d65fc6b02c5e5f1bb0869a466da3bbb09fe2bc536c32f3.png | simple | <table><tr><td>Medium</td><td>Carbon source</td><td>Rationale</td></tr><tr><td>DSMZ 65</td><td>Glucose Switchgrass MCC</td><td>DSMZ recommended <i>T. bispora</i> growth medium prepared with glucose</td></tr><tr><td>I/S</td><td>Glucose Switchgrass MCC</td><td>Previously reported actinobacteria isolation/screening medium... | <table><tr><td>Medium</td><td>Carbon source</td><td>Rationale</td></tr></table> | <table><tr><td>DSMZ 65</td><td>Glucose Switchgrass MCC</td><td>DSMZ recommended T. bispora growth medium prepared with glucose</td></tr><tr><td>I/S</td><td>Glucose Switchgrass MCC</td><td>Previously reported actinobacteria isolation/screening medium prepared with MCC (Waldron and Eveleigh, 1986)</td></tr><tr><td>M9TE</... |
288d7510d82176dee27d110fa9145d694be9e52f93af52e56a16aeb173ffe76d.png | simple | <table><tr><td>Inclusion criteria</td><td>Exclusion criteria</td></tr><tr><td>1. Written informed consent</td><td>1. Unstable asthma</td></tr><tr><td>2. Age 16 years or older</td><td>2. Presence of active lung disease other than asthma</td></tr><tr><td>3. Diagnosis of asthma by a health professional and duration of ast... | <table><tr><td>Inclusion criteria</td><td>Exclusion criteria</td></tr><tr><td>1. Written informed consent</td><td>1. Unstable asthma</td></tr><tr><td>2. Age 16 years or older</td><td>2. Presence of active lung disease other than asthma</td></tr></table> | <table><tr><td>3. Diagnosis of asthma by a health professional and duration of asthma symptoms ≥ 1 year.</td><td>3. Mental impairment or language difficulties that make informed consent impossible.</td></tr><tr><td>4. Asthma Control Questionnaire score (6 questions version) greater than or equal to 1 (suggesting poorly... |
fc6901bc0c1499c3837baae7118ed351d6cb1a4927b6513420e31abaee2626a4.png | simple | <table><tr><td>Confounder</td><td>Slope</td><td>95 % CI</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>0.009</td><td>−0.020, 0.039</td><td>0.537</td></tr><tr><td>% Males</td><td>−0.011</td><td>−0.024, 0.002</td><td>0.106</td></tr><tr><td>% Diabetics</td><td>0.003</td><td>−0.002, 0.0... | <table><tr><td>Confounder</td><td>Slope</td><td>95 % CI</td><td>P value</td></tr><tr><td>Age (years)</td><td>0.009</td><td>−0.020, 0.039</td><td>0.537</td></tr></table> | <table><tr><td>Confounder</td><td>Slope</td><td>95 % CI</td><td>P value</td></tr><tr><td>% Males</td><td>−0.011</td><td>−0.024, 0.002</td><td>0.106</td></tr><tr><td>% Diabetics</td><td>0.003</td><td>−0.002, 0.008</td><td>0.255</td></tr><tr><td>% Smokers</td><td>−0.004</td><td>−0.009, 0.0004</td><td>0.075</td></tr><tr><... |
68075b5db5fff98606b050b2969e1d20d9124a747c5b5ab3f64c85a83545053d.png | complex | <table><tr><td></td><td></td><td colspan="2">Unstable housing</td><td></td><td></td></tr><tr><td>Characteristic</td><td>Total n (%)</td><td>Yes 1713 (69.8)</td><td>No<sup>2</sup>722 (29.4)</td><td>Odds ratio (95% CI)</td><td><i>p</i>-value</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td></tr><t... | <table><tr><td></td><td></td><td colspan="2">Unstable housing</td><td></td><td></td></tr><tr><td>Characteristic</td><td>Total n (%)</td><td>Yes 1713 (69.8)</td><td>No2722 (29.4)</td><td>Odds ratio (95% CI)</td><td>p-value</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td... | <table><tr><td></td><td></td><td colspan="2">Unstable housing</td><td></td><td></td></tr><tr><td>Characteristic</td><td>Total n (%)</td><td>Yes 1713 (69.8)</td><td>No2722 (29.4)</td><td>Odds ratio (95% CI)</td><td>p-value</td></tr><tr><td>No</td><td>1538 (62.7)</td><td>1049 (61.2)</td><td>478 (66.2)</td><td>1.24 (1.04-... |
1192fa168a05f0e73cf6568e23fa9be5f6fed1ba4a3154d2dff2c6c2e51015e2.png | simple | <table><tr><td></td><td></td><td>OR (95% CI)</td><td>P</td></tr><tr><td>Tvitals</td><td>Red</td><td>6.57 (2.25-19.17)</td><td>< 0.001</td></tr><tr><td></td><td>Orange</td><td>6.69 (3.29-13.58)</td><td>< 0.0001</td></tr><tr><td></td><td>Yellow</td><td>2.98 (1.31-5.45)</td><td>< 0.001</td></tr><tr><td></td><td>G... | <table><tr><td></td><td></td><td>OR (95% CI)</td><td>P</td></tr><tr><td>Tvitals</td><td>Red</td><td>6.57 (2.25-19.17)</td><td>< 0.001</td></tr><tr><td></td><td>Orange</td><td>6.69 (3.29-13.58)</td><td>< 0.0001</td></tr><tr><td></td><td>Yellow</td><td>2.98 (1.31-5.45)</td><td>< 0.001</td></tr><tr><td></td><td>Green</td>... | <table><tr><td></td><td>Green</td><td>1.0</td><td></td></tr></table> |
414b51d36b3cd896e13845a8c786cc7a742a2e34a451a8b4e9eadaa6ca21b6d7.png | complex | <table><tr><td>Study groups and time points</td><td colspan="4">SF-36v2 scores, mean (SD)</td></tr><tr><td></td><td>Vitality</td><td>Social functioning</td><td>Role-emotional</td><td>Mental health</td></tr><tr><td>Hyal-Joint<sup>® </sup>(<i>n </i>= 8)</td><td></td><td></td><td></td><td></td></tr><tr><td> Baseline<... | <table><tr><td>Study groups and time points</td><td colspan="4">SF-36v2 scores, mean (SD)</td></tr><tr><td></td><td>Vitality</td><td>Social functioning</td><td>Role-emotional</td><td>Mental health</td></tr><tr><td>Hyal-Joint® (n = 8)</td><td></td><td></td><td></td><td></td></tr><tr><td>Baseline</td><td>49.4 (9.9)</td><... | <table><tr><td>Study groups and time points</td><td colspan="4">SF-36v2 scores, mean (SD)</td></tr><tr><td></td><td>Vitality</td><td>Social functioning</td><td>Role-emotional</td><td>Mental health</td></tr><tr><td>Change baseline vs week 8</td><td>3.5 (9.3)</td><td>2.0 (7.7</td><td>5.3 (6.2)</td><td>4.2 (9.7)</td></tr>... |
7c02d38eeec7d275f1b87027fbc39d6dbd2adee840f44b6782df44a98828270d.png | complex | <table><tr><td>Species</td><td>Group</td><td>R<sub>G</sub></td><td>R<sub>T</sub></td><td>Skew<sup>1</sup></td></tr><tr><td colspan="5">Chromosomes with strongest overall skew</td></tr><tr><td>Candidatus <i>Blochmannia floridanus</i></td><td>Gammaproteobacteria</td><td>0.433</td><td>0.107</td><td>0.446</td></tr><tr><td>... | <table><tr><td>Species</td><td>Group</td><td>RG</td><td>RT</td><td>Skew1</td></tr><tr><td colspan="5">Chromosomes with strongest overall skew</td></tr><tr><td>Candidatus Blochmannia floridanus</td><td>Gammaproteobacteria</td><td>0.433</td><td>0.107</td><td>0.446</td></tr><tr><td>Clostridium acetobutylicum ATCC 824</td>... | <table><tr><td>Gloeobacter violaceus PCC 7421</td><td>Cyanobacteria</td><td>0.003</td><td>-0.002</td><td>0.004</td></tr></table> |
2c22effac1a443c60021ee4269c7ec243da714a9695d3f75f09c34db13f82554.png | simple | <table><tr><td>Measured parameters</td><td>Group</td><td>Pre-dose</td><td>1 month</td><td>2 month</td></tr><tr><td></td><td>Placebo</td><td>24.53 + 2.55</td><td>24.33 + 2.28</td><td>24.33 + 2.46</td></tr><tr><td>Grip strength (Rt) (kg)</td><td>KP25</td><td>25.06 + 3.01</td><td>25 + 2.97</td><td>24.86 + 3.18</td></tr><t... | <table><tr><td>Measured parameters</td><td>Group</td><td>Pre-dose</td><td>1 month</td><td>2 month</td></tr><tr><td></td><td>Placebo</td><td>24.53 + 2.55</td><td>24.33 + 2.28</td><td>24.33 + 2.46</td></tr><tr><td>Grip strength (Rt) (kg)</td><td>KP25</td><td>25.06 + 3.01</td><td>25 + 2.97</td><td>24.86 + 3.18</td></tr><t... | <table><tr><td>Measured parameters</td><td>Group</td><td>Pre-dose</td><td>1 month</td><td>2 month</td></tr><tr><td>Tandem test (Closed Eye, Right leg is in front) (sec)</td><td>KP25</td><td>31.86 ± 10.12</td><td>32.6 ± 7.44</td><td>32.73 + 7.67</td></tr><tr><td></td><td>KP90</td><td>31.26 ± 11.09</td><td>31.86 ± 9.33</... |
75bd3853902c335de22ae4a1b6f0fb3cb38c70cbb0413e52e73d0984cd540531.png | complex | <table><tr><td colspan="3">Adhesive systems</td></tr><tr><td>Name of the adhesive</td><td>Type of adhesives</td><td>Components</td></tr><tr><td rowspan="3">SBMP</td><td rowspan="3">ER, 3 steps</td><td>Phosphoric acid (35%)</td></tr><tr><td>Primer = HEMA, polyalkenoic acid copolymer, water</td></tr><tr><td>Bonding = HEM... | <table><tr><td colspan="2">Adhesive systems</td></tr><tr><td>Name of the adhesive</td><td>Type of adhesives</td></tr><tr><td rowspan="3">SBMP</td><td rowspan="3">ER, 3 steps</td></tr><tr></tr><tr></tr><tr><td rowspan="2">SB1</td><td rowspan="2">ER, 2 steps</td></tr><tr></tr><tr><td rowspan="2">ADSE</td><td rowspan="2">... | <table><tr><td>Adhesive systems</td></tr><tr><td>Components</td></tr><tr><td>Phosphoric acid (35%)</td></tr><tr><td>Primer = HEMA, polyalkenoic acid copolymer, water</td></tr><tr><td>Bonding = HEMA, Bis-GMA, amines, photoinitiator</td></tr><tr><td>Phosphoric acid (35%)</td></tr><tr><td>Adhesive (primer + bonding) = dim... |
a78b5afddfa1d4b184c6d445d22854b4f287c36beaa54b85409ebb681bfdd1ff.png | simple | <table><tr><td></td><td>2012 Logistic Regression Deviance</td><td>2012 Logistic Regression Deviance Rank</td><td>2013 Logistic Regression Deviance</td><td>2013 Logistic Regression Deviance Rank</td><td>2014 Logistic Regression Deviance</td><td>2014 Logistic Regression Deviance Rank</td><td>2012–2014 Logistic Regr... | <table><tr><td></td></tr><tr><td>Age</td></tr><tr><td>Pneumococcal Vaccination</td></tr><tr><td>Time Since Last Checkup</td></tr><tr><td>Number of Personal Doctors</td></tr><tr><td>Employment</td></tr><tr><td>Annual Household Income</td></tr><tr><td>Smoking Status</td></tr><tr><td>Health Care Coverage</td></tr><tr><td>... | <table><tr><td>2012 Logistic Regression Deviance</td><td>2012 Logistic Regression Deviance Rank</td><td>2013 Logistic Regression Deviance</td><td>2013 Logistic Regression Deviance Rank</td><td>2014 Logistic Regression Deviance</td><td>2014 Logistic Regression Deviance Rank</td><td>2012–2014 Logistic Regression Mean Dev... |
bdeae50d1767987cc584b680103451354951b01884023c0553a4a123577289eb.png | complex | <table><tr><td>Characteristics</td><td>Total164 (%)</td><td>Died<i>N</i> = 32(%)</td><td>Survived132(%)</td><td><i>p</i>-Value</td></tr><tr><td colspan="5">Maternal age</td></tr><tr><td>< 20 years</td><td>23 (14.0)</td><td>4 (17.4)</td><td>19 (82.6)</td><td></td></tr><tr><td>≥ 20 years</td><td>141 (86.0)</td><... | <table><tr><td>Characteristics</td><td>Total164 (%)</td></tr><tr><td colspan="2">Maternal age</td></tr><tr><td>< 20 years</td><td>23 (14.0)</td></tr><tr><td>≥ 20 years</td><td>141 (86.0)</td></tr><tr><td colspan="2">Maternal education</td></tr><tr><td>None</td><td>7 (4.3)</td></tr><tr><td>Primary</td><td>49 (29.9)</td>... | <table><tr><td>DiedN = 32(%)</td><td>Survived132(%)</td><td>p-Value</td></tr><tr><td colspan="3">Maternal age</td></tr><tr><td>4 (17.4)</td><td>19 (82.6)</td><td></td></tr><tr><td>28 (20.0)</td><td>113 (80.0)</td><td>0.78</td></tr><tr><td colspan="3">Maternal education</td></tr><tr><td>2 (28.6)</td><td>5 (71.4)</td><td... |
674b99709f378d01f2fd608d3e292764a1466063bf3dd887a46566888422b66a.png | complex | <table><tr><td></td><td>PID with chlamydia (<i>N</i> = 175)</td><td>PID without chlamydia (<i>N</i> = 322)</td><td><i>P</i></td></tr><tr><td>Mean age (years)</td><td>27.9 ± 8.2</td><td>32.4 ± 8.3</td><td><0.0001</td></tr><tr><td>Married (%)</td><td>71 (40.6)</td><td>223 (69.3)</td><td><0.0001</td></tr><... | <table><tr><td></td><td>PID with chlamydia (N = 175)</td><td>PID without chlamydia (N = 322)</td><td>P</td></tr><tr><td>Mean age (years)</td><td>27.9 ± 8.2</td><td>32.4 ± 8.3</td><td><0.0001</td></tr><tr><td>Married (%)</td><td>71 (40.6)</td><td>223 (69.3)</td><td><0.0001</td></tr><tr><td>Parity</td><td>0.7 ± 0.9</td><... | <table><tr><td></td><td>PID with chlamydia (N = 175)</td><td>PID without chlamydia (N = 322)</td><td>P</td></tr><tr><td>Alcohol (%)</td><td>72 (41.1)</td><td>107 (33.2)</td><td>0.096</td></tr><tr><td>Smoking (%)</td><td>45 (25.7)</td><td>74 (22.3)</td><td>0.510</td></tr></table> |
448ec286e029d700a99265175799fc36198bd830121500299fc4e1a96bc0eb44.png | simple | <table><tr><td></td><td>Non-op</td><td>Plate</td><td>TEN</td></tr><tr><td>Number</td><td>37</td><td>41</td><td>24</td></tr><tr><td>Age in years (stand. dev.)</td><td>41 (18)</td><td>38 (15)</td><td>34 (14.5)</td></tr><tr><td>Robinson classification 2B1/B2</td><td>24/13</td><td>14/27</td><td>17/7</td></tr><tr><td>Non-un... | <table><tr><td></td><td>Non-op</td><td>Plate</td></tr><tr><td>Number</td><td>37</td><td>41</td></tr><tr><td>Age in years (stand. dev.)</td><td>41 (18)</td><td>38 (15)</td></tr><tr><td>Robinson classification 2B1/B2</td><td>24/13</td><td>14/27</td></tr><tr><td>Non-union (%)</td><td>2 (5.4)</td><td>0</td></tr><tr><td>Ope... | <table><tr><td>TEN</td></tr><tr><td>24</td></tr><tr><td>34 (14.5)</td></tr><tr><td>17/7</td></tr><tr><td>1 (4.2)</td></tr><tr><td>11 (46)</td></tr><tr><td>1 delayed union (healed with ultrasound), 2 lateral dislocations of the TEN, 1 prominent nail medially: required shortening in local anesthesia</td></tr><tr><td>8.4 ... |
1fca184589a81c57adf3d96356357358c2d1f36699d8e558d68cc936d6915465.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="3">Number (%)</td></tr><tr><td>Male </td><td>Female</td><td>Total</td></tr><tr><td>Presence of diabetes related complications </td><td>48 (70.6)</td><td>141 (84.9)</td><td>189 (80.8)</td></tr><tr><td>Presence of two or more concurrent diabetes complications</td><td>... | <table><tr><td rowspan="2">Variables</td><td colspan="3">Number (%)</td></tr><tr><td>Male</td><td>Female</td><td>Total</td></tr><tr><td>Presence of diabetes related complications</td><td>48 (70.6)</td><td>141 (84.9)</td><td>189 (80.8)</td></tr><tr><td>Presence of two or more concurrent diabetes complications</td><td>18... | <table><tr><td rowspan="2">Variables</td><td colspan="3">Number (%)</td></tr><tr><td>Male</td><td>Female</td><td>Total</td></tr><tr><td>Time of the diabetes related complication(s) diagnosis</td><td></td><td></td><td></td></tr><tr><td>Before being diagnosed with diabetes</td><td>19 (27.9)</td><td>43 (25.9)</td><td>62 (... |
d622620d8a4dc3e1bac62424d8e197702c95ec18df12a97b1bee0d9ecc9d96f1.png | simple | <table><tr><td>Medicine</td><td>Saving/unit (€)</td><td>Annual consumption</td><td>Annual saving (€)</td></tr><tr><td>IVIG</td><td>9.5/g</td><td>650 kg</td><td>6,175,000</td></tr><tr><td>Albumin</td><td>0.4/g</td><td>8,500 kg</td><td>1,360,000 (based on 40% market share)</td></tr><tr><td>FIX</td><td>0.04/IU... | <table><tr><td>Medicine</td><td>Saving/unit (€)</td><td>Annual consumption</td><td>Annual saving (€)</td></tr><tr><td>IVI</td><td>9</td><td>650</td><td>6,</td></tr></table> | <table><tr><td>G</td><td>.5/g</td><td> kg</td><td>175,000</td></tr><tr><td>Albumin</td><td>0.4/g</td><td>8,500 kg</td><td>1,360,000 (based on 40% market share)</td></tr><tr><td>FIX</td><td>0.04/IU</td><td>15 MIU</td><td>600,000</td></tr><tr><td>FVIII</td><td>0.02/IU</td><td>120 MIU</td><td>420,000 (based on 15% market ... |
6065e5040feb4dc2c870ab9cd641e156710882209a874e48217b4ed53f4242b0.png | complex | <table><tr><td></td><td colspan="3">Mortality</td></tr><tr><td></td><td>30-day</td><td>90-day</td><td>Overall</td></tr><tr><td>ICU cohort</td><td></td><td></td><td></td></tr><tr><td> Non-carrier</td><td>55/209 (26.3)</td><td>72/209 (34.4)</td><td>115/209 (55)</td></tr><tr><td> Carrier</td><td>11/28 (39.3)</td><td>14/28... | <table><tr><td></td><td colspan="3">Mortality</td></tr><tr><td></td><td>30-day</td><td>90-day</td><td>Overall</td></tr></table> | <table><tr><td></td><td colspan="3">Mortality</td></tr><tr><td>ICU cohort</td><td></td><td></td><td></td></tr><tr><td>Non-carrier</td><td>55/209 (26.3)</td><td>72/209 (34.4)</td><td>115/209 (55)</td></tr><tr><td>Carrier</td><td>11/28 (39.3)</td><td>14/28 (50)</td><td>23/28 (82.1)*</td></tr><tr><td>G1 cohort</td><td></t... |
643cd4028de08d1f1b58888004ae8ebd4fc475f1a0d4280aa0db2d8dddc1b418.png | complex | <table><tr><td rowspan="3"><i>Grade</i></td><td colspan="4">Patients</td></tr><tr><td colspan="4">35</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td></tr><tr><td>Neutropenia (<i>n</i>, %)</td><td>8 (22.8)</td><td>5 (14.2)</td><td>4 (11.4)</td><td>–</td></tr><tr><td>Anemia (<i>n</i>, %)</td><td>3 (8.5)</td><t... | <table><tr><td rowspan="3">Grade</td><td colspan="4">Patients</td></tr><tr><td colspan="4">35</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td></tr><tr><td>Neutropenia (n, %)</td><td>8 (22.8)</td><td>5 (14.2)</td><td>4 (11.4)</td><td>–</td></tr><tr><td>Anemia (n, %)</td><td>3 (8.5)</td><td>–</td><td>–</td><td>–</td... | <table><tr><td>Epistaxis (n, %)</td><td>27 (77.1)</td><td>2 (5.7)</td><td>–</td><td>–</td></tr><tr><td>Proteinuria (n, %)</td><td>–</td><td>1 (2.8)</td><td>–</td><td>–</td></tr><tr><td>Stomatitis (n, %)</td><td>15 (42.8)</td><td>2 (5.7)</td><td>1 (2.8)</td><td>–</td></tr><tr><td>Gingivitis (n, %)</td><td>1 (2.8)</td><t... |
cc1080628806b3fa69f4d35213e00e57e78e6c2ce7387472b37d330d0870e210.png | simple | <table><tr><td>C+1354T single nucleotide polymorphism</td><td>Systemic sclerosis patients (<i>n</i> = 115)</td><td>Control individuals (<i>n</i> = 140)</td></tr><tr><td>Genotype*</td><td></td><td></td></tr><tr><td> CC</td><td>103 (89.6)</td><td>108 (77.1)</td></tr><tr><td> CT</td><td>12 (10.4)</td><td>30 (21.4)</td></t... | <table><tr><td>C+1354T single nucleotide polymorphism</td><td>Systemic sclerosis patients (n = 115)</td><td>Control individuals (n = 140)</td></tr><tr><td>Genotype*</td><td></td><td></td></tr><tr><td>CC</td><td>103 (89.6)</td><td>108 (77.1)</td></tr><tr><td>CT</td><td>12 (10.4)</td><td>30 (21.4)</td></tr><tr><td>TT</td... | <table><tr><td>C</td><td>8)</td><td>.6)</td></tr><tr><td>T</td><td>12 (5.2)</td><td>34 (12.4)</td></tr></table> |
769847a3ce195c0f6d0dc62c355c0450f459ab19353a5915583a693f7c139624.png | complex | <table><tr><td>Metric</td><td></td><td>Observed</td><td>Predicted</td></tr><tr><td>Braiding intensity</td><td></td><td>6.8</td><td>6.4</td></tr><tr><td>Confluence node density, nodes km<sup>−2</sup></td><td></td><td>91</td><td>83</td></tr><tr><td rowspan="3">Least squares regression coefficient of determination, ... | <table><tr><td>Metric</td><td></td><td>Observed</td><td>Predicted</td></tr><tr><td>Braiding intensity</td><td></td><td>6.8</td><td>6.4</td></tr><tr><td>Confluence node density, nodes km−2</td><td></td><td>91</td><td>83</td></tr><tr><td rowspan="2">Least squares regression coefficient of determination, R2, for relations... | <table><tr><td>Least squares regression coefficient of determination, R2, for relationship between:</td><td>Bar convex perimeter</td><td>0.999</td><td>0.999</td></tr></table> |
d2fc6cebb3c8dd42a024d58ff01173222026dce36227b06d0076b36be532b9ff.png | complex | <table><tr><td colspan="4">β-catenin expression</td></tr><tr><td></td><td>Low (0–1)</td><td>High (2–3)</td><td></td></tr><tr><td>n(%)</td><td>53 (34.6)</td><td>100 (65.4)</td><td><i>p</i>-value</td></tr><tr><td>Age, years</td><td></td><td></td><td></td></tr><tr><td>< 65</td><td>28 (52.8)</td><td>48 ... | <table><tr><td colspan="4">β-catenin expression</td></tr><tr><td></td><td>Low (0–1)</td><td>High (2–3)</td><td></td></tr><tr><td>n(%)</td><td>53 (34.6)</td><td>100 (65.4)</td><td>p-value</td></tr><tr><td>Age, years</td><td></td><td></td><td></td></tr><tr><td>< 65</td><td>28 (52.8)</td><td>48 (48.0)</td><td>0.613</td></... | <table><tr><td>Missing</td><td>9</td><td>20</td><td></td></tr></table> |
2cdd39a37bba084e8a2c978942005d5a896991e5895fafb559c3cb1a2da230c0.png | simple | <table><tr><td>No.</td><td>ORF No.</td><td>Protein Name</td><td>MS/MASCOT Score</td><td>Mowse Score</td><td>% Coverage</td><td>Annotation</td><td>Putative kDa/pI</td><td>Calculated kDa/pI</td></tr><tr><td>1</td><td>2338</td><td><i>polA2*</i></td><td>15</td><td>39</td><td>13</td><td>DNA polymerase</td><td>150/4.38</td><... | <table><tr><td>No.</td><td>ORF No.</td><td>Protein Name</td><td>MS/MASCOT Score</td><td>Mowse Score</td><td>% Coverage</td><td>Annotation</td><td>Putative kDa/pI</td><td>Calculated kDa/pI</td></tr><tr><td>1</td><td>2338</td><td>polA2*</td><td>15</td><td>39</td><td>13</td><td>DNA polymerase</td><td>150/4.38</td><td>148.... | <table><tr><td>No.</td><td>ORF No.</td><td>Protein Name</td><td>MS/MASCOT Score</td><td>Mowse Score</td><td>% Coverage</td><td>Annotation</td><td>Putative kDa/pI</td><td>Calculated kDa/pI</td></tr><tr><td>19</td><td>1180</td><td>msrA</td><td>71</td><td></td><td>38</td><td>Peptide methionine sulfoxide red.</td><td>19.4/... |
907e4e56644af77bf5e6504517ccd3474aaf18a748673944f6f5cc89871de6bb.png | simple | <table><tr><td>Treatment groups (mg/kg)</td><td>% MNPCE (mean ± SD)</td><td>% PCE (mean ± SD)</td></tr><tr><td>Nondiabetic control</td><td>0.32 ± 0.08</td><td>48.4 ± 1.81</td></tr><tr><td>Nondiabetic + naringin (25)</td><td>0.30 ± 0.07</td><td>48.2 ± 2.16</td></tr><tr><td>Nondiabetic + nar... | <table><tr><td>Treatment groups (mg/kg)</td><td>% MNPCE (mean ± SD)</td><td>% PCE (mean ± SD)</td></tr><tr><td>Nondiabetic control</td><td>0.32 ± 0.08</td><td>48.4 ± 1.81</td></tr><tr><td>Nondiabetic + naringin (25)</td><td>0.30 ± 0.07</td><td>48.2 ± 2.16</td></tr><tr><td>Nondiabetic + naringin (50)</td><td>0.28 ± 0.08... | <table><tr><td>Diabetes</td><td>0.92 ± 0.13**</td><td>45.6 ± 3.97</td></tr><tr><td>Diabetes + naringin (25)</td><td>0.60 ± 0.12a</td><td>47.0 ± 2.54</td></tr><tr><td>Diabetes + naringin (50)</td><td>0.44 ± 0.11b</td><td>47.4 ± 2.40</td></tr></table> |
6e243b6ad4f784efb7a1a041a6887165d342630f8d3704d7ffbf6443f8d37cbf.png | complex | <table><tr><td>Organism</td><td>r</td><td>P-value</td></tr><tr><td>C185</td><td colspan="2">Constant</td></tr><tr><td>C212</td><td>0.791</td><td>0.034 *</td></tr><tr><td>C148</td><td>0.932</td><td>0.002 **</td></tr><tr><td>C119</td><td>0.791</td><td>0.034 *</td></tr><tr><td>C280</td><td>0.487</td><td>0.268</td></tr><tr... | <table><tr><td>Organism</td><td>r</td><td>P-value</td></tr><tr><td>C185</td><td colspan="2">Constant</td></tr><tr><td>C212</td><td>0.791</td><td>0.034 *</td></tr><tr><td>C148</td><td>0.932</td><td>0.002 **</td></tr></table> | <table><tr><td>Organism</td><td>r</td><td>P-value</td></tr><tr><td>C119</td><td>0.791</td><td>0.034 *</td></tr><tr><td>C280</td><td>0.487</td><td>0.268</td></tr><tr><td>C238</td><td>-0.791</td><td>0.034 *</td></tr><tr><td>C216</td><td colspan="2">Constant</td></tr><tr><td>C149</td><td>0.277</td><td>0.547</td></tr><tr><... |
299e3d1e567bf0aed69778456cb92e2fc0bae90f8e80b0e2c2e82a4003b0e459.png | complex | <table><tr><td>F0 male diet</td><td>CD</td><td>CD</td><td>HFD</td><td>HFD</td></tr><tr><td>F1 male diet</td><td>CD</td><td>HFD</td><td>CD</td><td>HFD</td></tr><tr><td>F<sub>1</sub> Male offspring</td><td><i>n </i>=<i> </i>14</td><td><i>n </i>=<i> </i>14</td><td><i>n </i>=<i> </i>20</td><td><i>n </i>=<i> </i>19</td></tr... | <table><tr><td>F0 male diet</td><td>CD</td><td>CD</td><td>HFD</td><td>HFD</td></tr><tr><td>F1 male diet</td><td>CD</td><td>HFD</td><td>CD</td><td>HFD</td></tr><tr><td>F1 Male offspring</td><td>n = 14</td><td>n = 14</td><td>n = 20</td><td>n = 19</td></tr><tr><td>Total body weight (g)1</td><td>36.4 ± 0.8 a</td><td>39.8 ±... | <table><tr><td colspan="5">Reproductive organs</td></tr><tr><td>Testes (g; L + R)</td><td>0.21 ± 0.01</td><td>0.20 ± 0.01</td><td>0.22 ± 0.01</td><td>0.22 ± 0.01</td></tr><tr><td>Seminal Vesicles (g; L + R)</td><td>0.36 ± 0.03 a</td><td>0.38 ± 0.04 ab</td><td>0.41 ± 0.03 ab</td><td>0.46 ± 0.03 b2</td></tr><tr><td>Gonad... |
012e114152c06e5ab575cdbc5ac0ee7ef0656103fdde8b44ac234ec3ddfa8f23.png | complex | <table><tr><td rowspan="2">Groups</td><td colspan="2">Mean ± standard deviation (h)</td><td rowspan="2">p-value</td></tr><tr><td>Misoprostol</td><td>Foley catheter</td></tr><tr><td>Latent phase</td><td>8.5 ± 5.1</td><td>10 ± 6.8</td><td>> 0.1</td></tr><tr><td>Time to delivery</td><td>11.08 ± 5.6<... | <table><tr><td rowspan="2">Groups</td><td colspan="2">Mean ± standard deviation (h)</td><td rowspan="2">p-value</td></tr><tr><td>Misoprostol</td><td>Foley catheter</td></tr><tr><td>Latent phase</td><td>8.5 ± 5.1</td><td>10 ± 6.8</td><td>> 0.1</td></tr></table> | <table><tr><td rowspan="2">Groups</td><td colspan="2">Mean ± standard deviation (h)</td><td rowspan="2">p-value</td></tr><tr><td>Misoprostol</td><td>Foley catheter</td></tr><tr><td>Time to delivery</td><td>11.08 ± 5.6</td><td>13.6 ± 16.9</td><td>< 0.05</td></tr></table> |
94d6e85d7d5bd2136ed8ba937a0b8b39795da1dba09ffb5f63e7fd63edc89f09.png | complex | <table><tr><td>Group</td><td colspan="2">Severity Scale</td><td colspan="2">Weekly occurrence</td></tr><tr><td></td><td>< 21</td><td>≥ 21</td><td>< 4 day</td><td>≥ 4 day</td></tr><tr><td>Day workers (Group A), n (%)</td><td>11 (50)</td><td>11 (50)</td><td>13 (59.1)</td><td>9 (40.9)</td></tr><tr><td>Ro... | <table><tr><td>Group</td><td colspan="2">Severity Scale</td><td colspan="2">Weekly occurrence</td></tr><tr><td></td><td>< 21</td><td>≥ 21</td><td>< 4 day</td><td>≥ 4 day</td></tr><tr><td>Day workers (Group A), n (%)</td><td>11 (50)</td><td>11 (50)</td><td>13 (59.1)</td><td>9 (40.9)</td></tr></table> | <table><tr><td>Group</td><td colspan="2">Severity Scale</td><td colspan="2">Weekly occurrence</td></tr><tr><td></td><td>< 21</td><td>≥ 21</td><td>< 4 day</td><td>≥ 4 day</td></tr><tr><td>Rotational shift workers, n (%)</td><td></td><td></td><td></td><td></td></tr><tr><td>- Group B</td><td>14 (36.8)</td><td>24 (63.2)</t... |
da6f31b8bc42a4053365ac0bee090486e5904a04b8634e45859933d6c9d4c12d.png | complex | <table><tr><td rowspan="2">Microbial agent</td><td colspan="2">Relative rate of incidence, n (%)</td></tr><tr><td>Early infections (39 episodes)</td><td>Late infections (187 episodes)</td></tr><tr><td>Coagulase-negative Staphylococci</td><td>20 (51.3)</td><td>56 (29.9)</td></tr><tr><td>Pseudomonas species</td><td>10 (2... | <table><tr><td rowspan="2">Microbial agent</td><td colspan="2">Relative rate of incidence, n (%)</td></tr><tr><td>Early infections (39 episodes)</td><td>Late infections (187 episodes)</td></tr><tr><td>Coagulase-negative Staphylococci</td><td>20 (51.3)</td><td>56 (29.9)</td></tr><tr><td>Pseudomonas species</td><td>10 (2... | <table><tr><td rowspan="2">Microbial agent</td><td colspan="2">Relative rate of incidence, n (%)</td></tr><tr><td>Early infections (39 episodes)</td><td>Late infections (187 episodes)</td></tr><tr><td>Enterococcus</td><td>/</td><td>4 (2.1)</td></tr><tr><td>Klebsiella pneumoniae</td><td>/</td><td>4 (2.1)</td></tr></tabl... |
14e4b7ccd793184ad52d5f6e46cb0b827869b71f24fe17da14588098b67b7f38.png | simple | <table><tr><td>Drug [brand or alternative name(s)]</td><td>Common clinical formulation(s) (USA unless stated otherwise)</td><td>Classification; origin</td><td>Clinical use</td><td>Cellular target</td></tr><tr><td>Buprenorphine (e.g., Suboxone, Subutex, Buprenex)</td><td>Buprenorphine hydrochloride, buprenorphine naloxo... | <table><tr><td>Drug [brand or alternative name(s)]</td><td>Common clinical formulation(s) (USA unless stated otherwise)</td><td>Classification; origin</td><td>Clinical use</td><td>Cellular target</td></tr><tr><td>Buprenorphine (e.g., Suboxone, Subutex, Buprenex)</td><td>Buprenorphine hydrochloride, buprenorphine naloxo... | <table><tr><td>Morphine (e.g., morphine sulfate ER, Roxanol, MsContin)</td><td>Morphine sulfate</td><td>Opiate; opium poppy (133)</td><td>Acute and chronic pain (Step 3 pain medication) (134)</td><td>Partial MOR agonist, weak DOR agonist (109, 135)</td></tr><tr><td>Oxycodone (e.g., Oxycontin, Norco, etc.)</td><td>Oxyco... |
11eed28fab235253b7390e08800689e282a422e7fc58acaa65c5b75c54152e5b.png | simple | <table><tr><td>Difficulties</td><td>Frequency (n = 59)**</td><td>Percentage</td></tr><tr><td>Institutional related</td><td></td><td></td></tr><tr><td>Few staff & heavy workload</td><td>20</td><td>33.9</td></tr><tr><td>Lack of testing kits and other logistical support</td><td>12</td><td>20.3</td></tr><tr><td>Occupat... | <table><tr><td>Difficulties</td><td>Frequency (n = 59)**</td><td>Percentage</td></tr><tr><td>Institutional related</td><td></td><td></td></tr><tr><td>Few staff & heavy workload</td><td>20</td><td>33.9</td></tr><tr><td>Lack of testing kits and other logistical support</td><td>12</td><td>20.3</td></tr><tr><td>Occupationa... | <table><tr><td>Difficulties</td><td>Frequency (n = 59)**</td><td>Percentage</td></tr><tr><td>Children cannot express themselves easily</td><td>8</td><td>13.6</td></tr><tr><td>Dependency nature of children</td><td>6</td><td>10.2</td></tr><tr><td>Children require more time for counselling</td><td>5</td><td>8.9</td></tr><... |
6e6d4770f882e0786dba542fdeeba8fed869fa76aed1d469b8e1379f794528d0.png | complex | <table><tr><td></td><td colspan="2">Median pericardial volume</td><td colspan="3">Univariate analysis</td></tr><tr><td>Parameters</td><td>Grade 2, 3</td><td>Grade 0</td><td>Odds ratio<sup>a</sup></td><td>95% CI</td><td><i>P</i> value</td></tr><tr><td>V5 Gy (%)</td><td>79.7 (51.8–100.0)</td><td>66.5 (45.7–88... | <table><tr><td></td><td colspan="2">Median pericardial volume</td><td colspan="3">Univariate analysis</td></tr><tr><td>Parameters</td><td>Grade 2, 3</td><td>Grade 0</td><td>Odds ratioa</td><td>95% CI</td><td>P value</td></tr></table> | <table><tr><td>V5 Gy (%)</td><td>79.7 (51.8–100.0)</td><td>66.5 (45.7–88.5)</td><td>1.08</td><td>1.03–1.13</td><td>0.0004</td></tr><tr><td>V10 Gy (%)</td><td>74.2 (46.5–97.6)</td><td>61.1 (40.8–84.7)</td><td>1.08</td><td>1.03–1.13</td><td>0.0003</td></tr><tr><td>V20 Gy (%)</td><td>68.2 (38.8–88.2)</td><td>53.4 (33–80.2... |
2ccc259ce5519adb077fbfa8239988d549e431657cbdebee1c607758bb06d8c3.png | simple | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Frequency</td><td>2.41 GHz</td></tr><tr><td>Transmitted Power Level</td><td>0 dBm</td></tr><tr><td>Antenna gain</td><td>5 dBi</td></tr><tr><td>Vertical plane angle resolution Δθ</td><td>1°</td></tr><tr><td>Horizontal plane angle resolution Δ	... | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Frequency</td><td>2.41 GHz</td></tr><tr><td>Transmitted Power Level</td><td>0 dBm</td></tr></table> | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Antenna gain</td><td>5 dBi</td></tr><tr><td>Vertical plane angle resolution Δθ</td><td>1°</td></tr><tr><td>Horizontal plane angle resolution Δφ</td><td>1°</td></tr><tr><td>Reflections</td><td>5</td></tr></table> |
0fc3a968e0bb3f2569614f788f6c92ad4543cd36a47ecd12d4c8f955b8e1987a.png | complex | <table><tr><td rowspan="2">Parameter, n (%)</td><td>Treatment-naïve patients</td></tr><tr><td>(<i>N</i> = 39)</td></tr><tr><td>At any time during study</td><td></td></tr><tr><td> Increase from baseline ≥10 mm Hg</td><td>12 (30.8)</td></tr><tr><td> Post-baseline IOP ≥25 mm Hg</td><td>15 (38.5)</td></tr... | <table><tr><td rowspan="2">Parameter, n (%)</td><td>Treatment-naïve patients</td></tr><tr><td>(N = 39)</td></tr><tr><td>At any time during study</td><td></td></tr></table> | <table><tr><td>Increase from baseline ≥10 mm Hg</td><td>12 (30.8)</td></tr><tr><td>Post-baseline IOP ≥25 mm Hg</td><td>15 (38.5)</td></tr><tr><td>Post-baseline IOP ≥35 mm Hg</td><td>5 (12.8)</td></tr><tr><td>At final visit</td><td></td></tr><tr><td>Increase from baseline ≥10 mm Hg</td><td>4 (10.3)</td></tr><tr><td>IOP ... |
61613186f8b070a8211369e1dace54a02ab9837f69c303aa96d6a9777d9aff68.png | complex | <table><tr><td>Consequence of muscle paralysis</td><td>Options for intervention</td></tr><tr><td rowspan="2">Motor weakness</td><td>Tendon transfer if muscle of adequate power (Grade V on the MRC scale) is available</td></tr><tr><td>Bracing if muscle of adequate power is not available</td></tr><tr><td rowspan="2">Muscl... | <table><tr><td>Consequence of muscle paralysis</td><td>Options for intervention</td></tr></table> | <table><tr><td rowspan="2">Motor weakness</td><td>Tendon transfer if muscle of adequate power (Grade V on the MRC scale) is available</td></tr><tr><td>Bracing if muscle of adequate power is not available</td></tr><tr><td rowspan="2">Muscle imbalance</td><td>Tendon transfer from stronger side of the joint to the weaker ... |
09370fbb4b62a1dadeae9988cdf2f7dd7d4158648feb0a807ee58201c64a4ddf.png | complex | <table><tr><td> </td><td colspan="2">Effect of Dex</td></tr><tr><td> </td><td>Fold change of AQP5 mRNA</td><td>Fold change of AQP5 protein</td></tr><tr><td>Dividing cells</td><td> </td><td> </td></tr><tr><td> <70% confluent</td><td>↓ 0–2x</td><td>↓ 0–2x</td></tr><tr><td>Nondividing cells</td>... | <table><tr><td></td><td colspan="2">Effect of Dex</td></tr><tr><td></td><td>Fold change of AQP5 mRNA</td><td>Fold change of AQP5 protein</td></tr><tr><td>Dividing cells</td><td></td><td></td></tr><tr><td><70% confluent</td><td>↓ 0–2x</td><td>↓ 0–2x</td></tr><tr><td>Nondividing cells</td><td></td><td></td></tr><tr><td>9... | <table><tr><td> confluent</td><td></td><td>4–6x</td></tr><tr><td>Matrigel treated cells</td><td>↓ 4–6x; after 2 h</td><td>↓ 4–6x; after 6 h</td></tr></table> |
033da487f2b78dcfcab72f8baf74480378739d0958ce541b710bc43c9b80b2b6.png | simple | <table><tr><td>Characteristic</td><td>Value</td></tr><tr><td>Age, years</td><td>71 (51; 78)</td></tr><tr><td>Height, cm</td><td>169 ± 7</td></tr><tr><td>Weight, kg</td><td>74 (72; 85)</td></tr><tr><td>Body mass index, kg/cm<sup>2</sup></td><td>26.4 (23.9; 30.1)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</... | <table><tr><td>Characteristic</td><td>Value</td></tr><tr><td>Age, years</td><td>71 (51; 78)</td></tr><tr><td>Height, cm</td><td>169 ± 7</td></tr></table> | <table><tr><td>Characteristic</td><td>Value</td></tr><tr><td>Weight, kg</td><td>74 (72; 85)</td></tr><tr><td>Body mass index, kg/cm2</td><td>26.4 (23.9; 30.1)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>21 (84%)</td></tr><tr><td>Female</td><td>4 (16%)</td></tr><tr><td>Simplified acute physiology score 2... |
a1c96b4a5b127692642118c3dac169ee825d2f239e27223c79b7c4336da3cab9.png | simple | <table><tr><td></td><td>PDB Entry</td><td>5WZE</td></tr><tr><td>Data collection</td><td>Space group</td><td>P 21 21 21</td></tr><tr><td></td><td>Cell dimension</td><td></td></tr><tr><td></td><td><i>a, b, c (Å)</i></td><td>111.197,123.432,149.485</td></tr><tr><td></td><td>α, β, γ (°)</td><td>90... | <table><tr><td></td><td>PDB Entry</td><td>5WZE</td></tr><tr><td>Data collection</td><td>Space group</td><td>P 21 21 21</td></tr><tr><td></td><td>Cell dimension</td><td></td></tr><tr><td></td><td>a, b, c (Å)</td><td>111.197,123.432,149.485</td></tr><tr><td></td><td>α, β, γ (°)</td><td>90, 90, 90</td></tr><tr><td></td><... | <table><tr><td>PDB Entry</td><td>5WZE</td></tr><tr><td>ater</td><td>153</td></tr><tr><td>B-factor</td><td></td></tr><tr><td>Protein</td><td>27.37</td></tr><tr><td>Ligand/ion</td><td>38.94</td></tr><tr><td>Water</td><td>30.89</td></tr><tr><td>R.m.s. deviations</td><td></td></tr><tr><td>Bond lengths (Å)</td><td>0.011</t... |
63e64b0ce8f5c499f5d8548a2338bb1dee6bbf767a0b73d3efef18d0fe8513d7.png | complex | <table><tr><td></td><td></td><td colspan="6">Test database MegaBLAST score</td></tr><tr><td>FAexpTRL</td><td>Annotation</td><td>Lp_MF</td><td>Zm_MF</td><td>Zm_TA</td><td>Hv_TA</td><td>Gm_TA</td><td>At_TA</td></tr><tr><td>LOC_Os04g16450</td><td>aquaporin PIP2.8, putative, expressed</td><td>470</td><td>357</td><td>351</t... | <table><tr><td></td><td></td><td colspan="6">Test database MegaBLAST score</td></tr><tr><td>FAexpTRL</td><td>Annotation</td><td>Lp_MF</td><td>Zm_MF</td><td>Zm_TA</td><td>Hv_TA</td><td>Gm_TA</td><td>At_TA</td></tr><tr><td>LOC_Os04g16450</td><td>aquaporin PIP2.8, putative, expressed</td><td>470</td><td>357</td><td>351</t... | <table><tr><td></td><td></td><td colspan="6">Test database MegaBLAST score</td></tr><tr><td>FAexpTRL</td><td>Annotation</td><td>Lp_MF</td><td>Zm_MF</td><td>Zm_TA</td><td>Hv_TA</td><td>Gm_TA</td><td>At_TA</td></tr><tr><td>LOC_Os10g21200</td><td>Photosystem Q, putative, expressed</td><td>936</td><td>1037</td><td>539</td>... |
54a00c7d11abdf200e43c16a1a4cd05a0f4958e3e856bacbc8119bf19cebece0.png | complex | <table><tr><td></td><td>B</td><td>SE <sup>a</sup></td><td>Sig</td><td colspan="2">95% CI for B</td></tr><tr><td>Lifetime anxiety</td><td>­0.151</td><td>0.216</td><td>0.487</td><td>­0.590</td><td>0.287</td></tr><tr><td>Lifetime depression</td><td>0.006</td><td>0.136</td><td>0.964</td><td>­0.271</td><td>0.... | <table><tr><td></td><td>B</td><td>SE a</td><td>Sig</td></tr><tr><td>Lifetime anxiety</td><td>0.151</td><td>0.216</td><td>0.487</td></tr><tr><td>Lifetime depression</td><td>0.006</td><td>0.136</td><td>0.964</td></tr><tr><td>Age</td><td>0.004</td><td>0.003</td><td>0.142</td></tr><tr><td>Employmentb</td><td></td><td></td... | <table><tr><td colspan="2">95% CI for B</td></tr><tr><td>0.590</td><td>0.287</td></tr><tr><td>0.271</td><td>0.283</td></tr><tr><td>0.001</td><td>0.009</td></tr><tr><td></td><td></td></tr><tr><td>0.368</td><td>0.207</td></tr><tr><td>0.423</td><td>0.003</td></tr><tr><td></td><td></td></tr><tr><td>0.230</td><td>0.0... |
d119a3e1f801473d0e5496b2a3f08ba4cf65b27f3af161004ea433887f5ac952.png | complex | <table><tr><td></td><td colspan="9">Subgroup 1 (<i>n</i> = 11) VPIT test performance without support</td></tr><tr><td>VPIT parameters</td><td>Test Mean ± SD</td><td>Retest Mean ± SD</td><td>Test-Retest Mean difference ± SD</td><td>Kendall’s tau correlation</td><td>Kendall’s tau correlation wi... | <table><tr><td></td><td colspan="9">Subgroup 1 (n = 11) VPIT test performance without support</td></tr><tr><td>VPIT parameters</td><td>Test Mean ± SD</td><td>Retest Mean ± SD</td><td>Test-Retest Mean difference ± SD</td><td>Kendall’s tau correlation</td><td>Kendall’s tau correlation with transformed data</td><td>ICC (9... | <table><tr><td></td><td colspan="9">Subgroup 1 (n = 11) VPIT test performance without support</td></tr><tr><td>VPIT parameters</td><td>Test Mean ± SD</td><td>Retest Mean ± SD</td><td>Test-Retest Mean difference ± SD</td><td>Kendall’s tau correlation</td><td>Kendall’s tau correlation with transformed data</td><td>ICC (9... |
9536b2473342be1967bd9a74d6ea39b4dceeb3175cf57234d5b4dec0d941777d.png | simple | <table><tr><td></td><td>SUL</td><td>PAF</td><td>PTV</td><td>PAD</td><td>PBT</td><td>BAU</td><td>BOB</td><td>BPN</td><td>BFL</td></tr><tr><td>Gene number</td><td>6</td><td>13</td><td>13</td><td>13</td><td>5</td><td>26</td><td>18</td><td>18</td><td>18</td></tr><tr><td>dS/t</td><td>1.5 × 10<sup>-10</sup></td><td>2.9 ... | <table><tr><td></td><td>SUL</td><td>PAF</td><td>PTV</td><td>PAD</td><td>PBT</td><td>BAU</td><td>BOB</td><td>BPN</td><td>BFL</td></tr><tr><td>Gene number</td><td>6</td><td>13</td><td>13</td><td>13</td><td>5</td><td>26</td><td>18</td><td>18</td><td>18</td></tr></table> | <table><tr><td></td><td>SUL</td><td>PAF</td><td>PTV</td><td>PAD</td><td>PBT</td><td>BAU</td><td>BOB</td><td>BPN</td><td>BFL</td></tr><tr><td>dS/t</td><td>1.5 × 10-10</td><td>2.9 × 10-09</td><td>3.6 × 10-09</td><td>4.8 × 10-09</td><td>1.3 × 10-08</td><td>1.1 × 10-08</td><td>7.9 × 10-08</td><td>6.4 × 10-08</td><td>8.9 × ... |
4826b5c76d4aad712511560e79b561d99018a4bea14c1fdf98a5dbbc65f064ef.png | simple | <table><tr><td>Rank</td><td>Microbe</td><td>Evidence</td></tr><tr><td>1</td><td><i>Helicobacter pylori</i></td><td>PMID:24782613</td></tr><tr><td>2</td><td><i>Clostridium difficile</i></td><td>PMID:23734349</td></tr><tr><td>3</td><td><i>Prevotella</i></td><td>PMID:23613868</td></tr><tr><td>4</td><td><i>Actinobacteria</... | <table><tr><td>Rank</td><td>Microbe</td><td>Evidence</td></tr><tr><td>1</td><td>Helicobacter pylori</td><td>PMID:24782613</td></tr><tr><td>2</td><td>Clostridium difficile</td><td>PMID:23734349</td></tr><tr><td>3</td><td>Prevotella</td><td>PMID:23613868</td></tr><tr><td>4</td><td>Actinobacteria</td><td>PMID:23613868</td... | <table><tr><td>Rank</td><td>Microbe</td><td>Evidence</td></tr><tr><td>9</td><td>Bacteroides</td><td>PMID:20140211</td></tr><tr><td>10</td><td>Enterobacteriaceae</td><td>PMID:25759592</td></tr></table> |
6ca2093326dfb092ee373951f29e11677db5802158f2220c8d899296d9a39038.png | simple | <table><tr><td> </td><td>Pre (N=174)</td><td>During (N=116)</td><td>Post (N=174)</td><td>Overall (N=464)</td></tr><tr><td>Median age years (IQR)</td><td>76 (65–82)</td><td>74.5 (61–84)</td><td>75 (62–83)</td><td>75 (62–83)</td></tr><tr><td>Female (%)</td><td>81/174 (46.6)</td><td>63/116 (54.3)</... | <table><tr><td></td><td>Pre (N=174)</td><td>During (N=116)</td><td>Post (N=174)</td><td>Overall (N=464)</td></tr><tr><td>Median age years (IQR)</td><td>76 (65–82)</td><td>74.5 (61–84)</td><td>75 (62–83)</td><td>75 (62–83)</td></tr><tr><td>Fe</td><td>81/</td><td>63/116 (54.3</td><td>97/174 (55</td><td>241/464</td></tr><... | <table><tr><td></td><td>Pre (N=174)</td><td>During (N=116)</td><td>Post (N=174)</td><td>Overall (N=464)</td></tr><tr><td>male (%)</td><td>174 (46.6)</td><td>)</td><td>.7)</td><td> (51.9)</td></tr><tr><td>Dispatched as stroke (%) (all diagnoses)</td><td>134/168 (79.8)</td><td>105/111 (94.6)</td><td>159/171 (93.0)</td><t... |
156a5e4d1fd7e91202dc3411272cb14e7e7d0f986573c3d0baa0eccb404c82aa.png | simple | <table><tr><td>Variable</td><td>No.<sup>#</sup> N = 346</td><td>3-year OS (%)</td><td>p-value</td><td>3-year LRFS (%)</td><td>p-value</td><td>3-year DFS (%)</td><td>p-value</td></tr><tr><td>Age</td><td></td><td></td><td>0.002</td><td></td><td>0.001</td><td></td><td>0.008</td></tr><tr><td><50 y</td><td>225</td><td>87... | <table><tr><td>Variable</td><td>No.# N = 346</td><td>3-year OS (%)</td><td>p-value</td><td>3-year LRFS (%)</td><td>p-value</td><td>3-year DFS (%)</td><td>p-value</td></tr><tr><td>Age</td><td></td><td></td><td>0.002</td><td></td><td>0.001</td><td></td><td>0.008</td></tr><tr><td><50 y</td><td>225</td><td>87</td><td></td>... | <table><tr><td>Variable</td><td>No.# N = 346</td><td>3-year OS (%)</td><td>p-value</td><td>3-year LRFS (%)</td><td>p-value</td><td>3-year DFS (%)</td><td>p-value</td></tr><tr><td>Overall stage</td><td></td><td></td><td>0.038</td><td></td><td>0.684</td><td></td><td>0.024</td></tr><tr><td>III</td><td>53</td><td>92</td><t... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.